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Abstract 
ABSTRACT 
Jaan Kirss Jr. 
Diagnosis and Treatment of Obstetric Anal Sphincter Injuries (OASI) 
University of Turku, Faculty of Medicine, Department of Surgery, Doctoral 
Programme in Clinical Research, The Division of Digestive Surgery and 
Urology, Turku University Hospital, Turku, Finland 
 
Annales Universitatis Turkuensis 
Painosalama OY, Turku, Finland 2019 
Aims: The aims of this study were to identify the risk factors for a failed 
primary repair of obstetric anal sphincter injury (OASI), to determine 
whether external phased-array magnetic resonance imaging (MRI) is suit-
able for the diagnosis of residual obstetric anal sphincter injury (ROASI), 
and to evaluate the effectiveness of sacral neuromodulation (SNM) for the 
treatment of faecal incontinence (FI) in women with a history of OASI.  
Patients and Methods: A total of 60 women with a history of OASI were 
analysed for factors influencing the failure of primary sphincter repair. 
Forty women who had been diagnosed with OASI underwent both MRI 
and three-dimensional endoanal ultrasound (3D EAUS) imaging 6–8 
months postpartum. The results from these imaging studies were ana-
lysed. Data of all patients tested for SNM in Finland was gathered, patients 
with FI as the indication for SNM treatment were further analysed.  
Results: The risk factors for a failed primary sphincter repair were repairs 
executed by inexperienced personnel (p<0.001), or during on-call hours 
(p=0.039), end-to-end suturing of the external anal sphincter (p=0.030), and 
failure to prescribe antibiotics or laxatives (p<0.001). External phased-array 
pelvic MRI is comparable to 3D EAUS in detecting external anal sphincter 
(EAS) lesions (κ=0.510). SNM treatment outcomes were more successful in 
patients with obstetric FI, compared to patients with other types of FI 
(p=0.012). The presence of a sphincter lesion or previous sphincter repair 
had no effect on the SNM treatment outcome (p=0.425).  
Conclusions: There were clear risk factors that can affect the outcome of 
the primary repair of OASI. ROASI can be successfully imaged by external 
phased-array MRI. SNM treatment outcomes of patients with ROASI were 
comparable if not better than outcomes in patients with other causes of FI. 
A patent sphincter defect or previous sphincteroplasty (SP) had no effect 
on SNM treatment outcomes.  
Keywords: obstetric anal sphincter injury, faecal incontinence, magnetic 
resonance imaging, sacral neuromodulation 
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Tavoitteet: Tutkimuksen tavoitteena oli selvittää sulkijalihasrepeämän 
korjauksen pettämiseen liittyviä riskitekijöitä, magneettikuvauksen (MRI) 
soveltuvuutta sulkijalihasrepeämien diagnostiikassa ja sakraalihermomo-
dulaation (SNM) sopivuutta sulkijalihasvaurioiden aiheuttaman ulosteen-
karkailun (UK) hoidossa. 
Aineisto ja menetelmät: Tutkimukseen kerättiin 60 sulkijalihasrepeämä-
potilaan tiedot. Tämän potilasaineiston perustella selvitettiin, mitkä olivat 
sulkijalihaskorjauksen epäonnistumisen riskitekijät. Yhteensä 40 potilasta 
osallistui prospektiiviseen tutkimukseen, jossa verrattiin MRI:tä ja endo-
anaali ultraäänitutkimusta (EAUS) sulkijalihasrepeämien toteamisessa. 
Tutkimukseen kerättiin myös kaikki Suomessa SNM:lla hoidettujen poti-
laiden tiedot. Tutkimukseen otettiin mukaan potilaat, joilla oli SNM:n in-
dikaationa UK.  
Tulokset: Riskiä sulkijalihasrepeämän korjauksen epäonnistumiseen lisäsi 
se, että repeämän oli korjannut kokematon lääkäri tai kätilö (p<0.001), kor-
jaus oli tehty päivystysaikana (p=0.039), repeämä oli korjattu pää päätä 
vasten (p=0.030) ja se, että potilaille ei ollut korjauksen jälkeen määrätty 
antibiootteja tai ulostuslääkettä (p<0.001). MRI oli yhtä tarkka kuin EAUS 
sulkijalihasrepeämien toteamisessa (=0.510). SNM:n tulokset olivat pa-
remmat potilailla, joilla oli idiopaattinen UK tai UK:n syynä oli sulkijali-
hasrepeämä (p=0.012). Sulkijalihasrepeämä tai aiempi sulkijalihasten kor-
jausleikkaus ei vaikuttanut SNM:n tuloksiin (p=0.425). 
Johtopäätökset: Sulkijalihasrepeämän korjauksen epäonnistumiseen löy-
tyi selviä riskitekijöitä. Sulkijalihasrepeämän voi todeta myös luotettavasti 
MRI:llä. SNM:n tulokset olivat sulkijalihasrepeämäpotilailla yhtä hyvät tai 
jopa paremmat kuin muilla karkailupotilailla. Sulkijalihasrepeämä tai 
aiempi sulkijalihasten korjausleikkaus ei vaikuttanut SNM:n tuloksiin. 
Avainsanat: Sulkijalihasrepeämä, ulosteenkarkailu, magneettikuvaus, 
sakraalihermomodulaatio
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1 INTRODUCTION 
The principal aetiological factor for developing faecal incontinence (FI) in 
women is obstetric anal sphincter injury (OASI) (Jango et al. 2017a, 
Goldman et al. 2018). There were 52,000 births registered in Finland in 
2016; 1.2% of the registered deliveries complicated in OASI (Heino et al. 
2017). Although OASI is to some extent a preventable injury (Jango et al. 
2014), it is not abolishable. As long as women are giving birth, there is a 
risk of developing perineal tears. In order to achieve the best possible out-
comes for the treatment of this injury, physicians must be prepared to di-
agnose and treat OASI adequately. The cornerstone of a favourable out-
come in the treatment of OASI is a well-executed primary repair. This is 
naturally coupled with adequate diagnosis of a postpartum sphincter in-
jury (Oberwalder et al. 2004, Malouf et al. 2000a, Pinta et al. 2004a). Making 
a right diagnosis and repairing the defect can be challenging, due to the 
profuse bleeding, swelling, and extensive tissue damage that can result 
from vaginal delivery. The repair of OASI is a difficult surgical interven-
tion in very unfriendly conditions. Postponing the repair until experienced 
personnel are available and the repair can be undertaken in operating 
room conditions has been deemed acceptable. A delay up to 24 hours will 
not have a negative effect on the outcome (Dudding et al. 2008a, Soerensen 
et al. 2008). 
Follow-up after OASI is crucial for recognising residual tears and facilitat-
ing their timely repair (Soerensen et al. 2008).   
Sphincter imaging is the only option for reliably evaluating residual 
sphincter defects (Dobben et al. 2006, Jeppson et al. 2012). For the last two 
decades, endoanal ultrasound (EAUS) has been the gold standard for im-
aging the anal sphincter complex and diagnosing anal sphincter lesions. 
Alternatively, endoanal magnetic resonance imaging (MRI) can be used to 
image the anal sphincter complex. Endoanal MRI has been shown to be as 
precise as three-dimensional endoanal ultrasound (3D EAUS) in diagnos-
ing external anal sphincter defects (Deutekom et al. 2007, West et al. 2005). 
Both the endoanal MRI and 3D EAUS require specialised hardware, which 
is not widely available. The ever-improving quality of external phased-ar-
ray pelvic MRI has facilitated imaging the anal sphincters without endo-
anal coils. This allows smaller centres where pelvic MRI is available to con-
duct imaging of patients with a history of OASI.  
12 Introduction 
After the diagnosis of a residual obstetric anal sphincter injury (ROASI), 
most women are referred to a physiotherapist for biofeedback therapy. 
Simultaneously they are prescribed fibre supplements and, if needed anti-
diarrhoeal agents such as loperamide. Women with no visible perineal de-
fects are mostly treated conservatively with considerable success 
(Duelund-Jakobsen et al. 2016, Benezech et al. 2016, Ribas and Munoz-
Duyos 2018). When diagnosed early, the sphincter defect can still be re-
paired surgically with acceptable short- and medium-term outcomes 
(Pinta et al. 2001, Molander et al. 2007, Soerensen et al. 2014). This only 
applies to women with symptomatic FI. Sphincteroplasty (SP) years from 
the initial injury is associated with poor treatment outcomes, though evi-
dence on this matter is somewhat contradictory. A study by Pinta et al. 
(2001) showed patients age to have a negative effect on secondary SP out-
comes. Published material on this matter has been contradictory, with 
some studies showing age not to have an effect on the success or failure of 
secondary SP (Malouf et al. 2000a, Johnson et al. 2010) and other studies 
showing age to have a negative impact on the outcomes of secondary SP 
(Pinta et al. 2001, Engel et al. 1994, Sitzler and Thomson 1996, Nikiteas et 
al. 1996, Bravo et al. 2004, Lamblin et al. 2014). 
The treatment of ROASI has been a subject of debate in recent years. Cur-
rently, SNM has been advocated for patients with FI unresponsive to con-
servative treatment. Previous studies suggest that SNM treatment can be 
successful even in the presence of a patent sphincter lesion. SNM was con-
ceived in 1982 as a treatment modality for urinary incontinence (Tanagho 
and Schmidt 1982). Since then the implications for SNM have evolved, and 
it has become the first line surgical treatment for FI (Goldman et al. 2018). 
The aim of this doctoral thesis is to determine the risk factors for failure of 
primary repair of OASI, evaluate the possibility of imaging the anal sphinc-
ter complex with external phased-array pelvic MRI, and determine the ef-
fectiveness of SNM treatment for FI in patients with a history of OASI. Ad-
ditionally, we shall evaluate the effect of a patent obstetric sphincter lesion 
or previous attempts at sphincter repair on SNM treatment.   
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2 REVIEW OF LITERATURE 
2.1 History of obstetric anal sphincter injuries 
The oldest evidence of OASI dates back to 2050 BC in ancient Egypt. The 
mummy of one of King Menuhotep II’s wives was found to have an exten-
sive perineal tear involving the bladder and the rectum. This individual 
most probably perished from these wounds. Since then many notable 
names in the history of medicine such as Celsus, William Harvey, and Am-
broise Paré have expressed opinions on perineal injuries. Paré, the father 
of surgical obstetrics, was the first to describe suturing of the sphincter lac-
eration. Paré went on to found a school for midwives in Paris (Ellis 2009, 
Drife 2002, Dunn 1994, Vinchon 2009).  
In 1930 Royston described a method of approximation of the anal sphincter 
tear with sutures. The current method of end-to-end SP was described in 
1955 by Cunningham. The overlapping SP with a separate internal anal 
sphincter (IAS) repair was first described by Parks and McPartlin (1971) as 
a method of secondary SP. The same method for sphincter repair immedi-
ately postpartum was described in 1999 by Sultan et al. 
2.2 Anatomy 
2.2.1 Anatomy of the female pelvis 
The female pelvis consists of the bony pelvis, which forms the pelvic ring, 
and a muscular pelvic floor. The sides of the bony pelvis form the lateral 
walls of the pelvic cavity. The pelvic floor, which is comprised of muscular 
structures, forms the base of the pelvic cavity. The bony pelvis has a cylin-
drical structure. The ends of the cylinder form the pelvic inlet and the pel-
vic outlet. The pelvic inlet is bordered by the sacral promontory posteri-
orly, the arcuate lines of the iliac bones laterally, and the superior margin 
of the pubic rami anteriorly. The pelvic outlet is bordered by the coccyx 
posteriorly, the tuberositas of the ischial bone, and the lower ramus of the 
pubic bone (Figure 1) (Thomas and Au-Yong 2011, Craig and Billow 2018). 
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The pelvic floor is formed of several layers of muscles and ligaments. Its 
primary function is to support the load of the visceral organs and contain 
them in their proper positions. Pelvic floor musculature is also responsible 
for controlling continence. Both the rectal and the urogenital openings lie 
on the pelvic floor and are controlled by its muscles.  
The posteriolateral part of the female pelvic floor is composed of the leva-
tor ani and coccygeus muscles. Both muscles attach to the inner spine of 
the ischium, the coccyx, and the anococcygeal ligament. The transverse 
perineal muscles also arise from the inner spine of the ischium but attach 
more anteriorly to the anterior aspect of the anus. The anterior part of the 
female pelvic floor is formed by the bulbocavernosus and ischiocavernosus 
muscles. Both of these muscles converge from the inner margin of the is-
chial bone to the lower aspect of the symphysis (Agur et al. 2013). 
Apart from the obvious differences in the pelvic floor organs and muscu-
lature, the female bony pelvis, particularly the pelvic outlet, is wider and 
shorter than the male pelvis. The diameter of the pelvic outlet can widen 
even further during delivery and remain wider postpartum (Garagiola et 
al. 1989). 
 
 
Figure 1 The bony pelvis. a- saggital view; b- coronal view. The rings represent 
the pelvic inlet and outlet 
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2.2.2 Anatomy of the anal sphincters 
The anal sphincter complex is comprised of two circular sphincter muscles: 
the external and the internal anal sphincter (EAS and IAS). In the proximal 
part, the EAS evolves into m. puborectalis, which envelops the rectum in its 
posterior aspect and attaches to the pubic symphysis anteriorly, forming a 
horseshoe-like arc. The EAS and m. puborectalis are comprised of striated 
muscle fibres and the IAS of smooth muscle fibres. IAS tone accounts for 
most (80%) of the anal resting pressure. Typically, an EAS defect or loss 
of EAS function results in urge incontinence while impaired IAS function 
results in involuntary loss of stool (Thomas and Au-Yong 2011, Craig and 
Billow 2018, Agur et al. 2013). 
The anal sphincter complex is innervated by the puborectalis and puden-
dal nerves, which arise from the S3 and S4 nerve roots (Agur et al. 2013).  
2.2.3 Anatomy and physiology of the sacral nerves 
The pelvic floor musculature is innervated by nerves originating from the 
sacral plexus. There are five sacral nerve roots (S1–S5) that exit from the 
corresponding sacral foramina. Of these, S2–S4 divide to form the puden-
dal nerve and give off parasympathetic fibres to the colon, rectum, bladder, 
anus and urogenital sphincters (Agur et al. 2013, Shafik 1995). The puden-
dal nerve itself carries only sympathetic fibres and has both afferent and 
efferent functions. It innervates the penis, the scrotum, the clitoris, and the 
labia. The pudendal nerve is also responsible for the afferent pathways of 
penile and clitoral erection as well as ejaculation. Its branches also supply 
sensation to the anal canal. Pudendal nerve branches, particularly the infe-
rior anal branch, innervate the muscles of the perineum, the pelvic floor, 
and the external anal and urethral sphincters. 
2.2.4 Physiology of continence 
In adults, continence is maintained by a complex sequence of neuromus-
cular signals. The pelvic floor muscles and m. puborectalis are normally at a 
constant state of contraction, also known as the postural reflex (Barleben 
and Mills 2010). This reflex arises from the sacral plexus. The puborectalis 
muscle plays a key role in achieving passive continence. Its tone creates a 
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steep angle between the anus and the rectum, which inhibits faeces from 
evacuating spontaneously. The anal sphincters comprise the active conti-
nence system. The IAS is responsible for the resting pressure of the anal 
canal. IAS is innervated by sympathetic motor neurons arising from the 
hypogastric nerves derived from the L5 nerve root and inhibitory para-
sympathetic innervation derived from the sacral plexus (S2-4) (Gordon 
2001, Mathews et al. 2013). When the rectum fills, the rising intrarectal 
pressure causes the inhibition of the postural reflex and thus relaxation of 
the puborectalis muscle.  The rise of intrarectal pressure causes the IAS to 
relax. During rectal filling continence is maintained by active contraction 
of the EAS, which is innervated by the pudendal nerves. When the relaxa-
tion of the pelvic floor and sphincter muscles is not coordinated, normal 
defecation does not occur (Palit et al. 2012).  
The fine sensory discrimination of the content of the rectum is achieved by 
receptors around the dentate line. Some sensory function is also attributed 
to the IAS, EAS and m. puborectalis, as the rectum is only sensitive to dis-
tention (Gordon 2001). 
2.3 Introduction to faecal incontinence (FI) 
Obstetric anal sphincter injures (OASI) often result in faecal incontinence 
(FI). As the treatment of OASI is in close conjunction with the treatment of 
FI, this chapter will give a short overview of the epidemiology, causes, di-
agnosis and general treatment options of FI. 
2.3.1 Epidemiology and causes of FI 
It is estimated that 2-5% of the adult population of Western countries suf-
fers from FI (Hayden and Weiss 2011, Ruiz and Kaiser 2017, Sharma et al. 
2016). According to a population-based study conducted in Finland, the 
incidence of FI among Finnish adults is 10.6% (Aitola et al. 2010). A more 
recent, large-scale study conducted in the United States revealed the prev-
alence of FI among adults to be 8.26% (Ditah et al. 2014). FI is more com-
mon among women, with two thirds of patients being female. FI is also 
more prevalent in the elderly population, with up to 50% of nursing home 
clients suffering from incontinence. (Aitola et al. 2010, Ruiz and Kaiser 
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2017, Hayden and Weiss 2011). The true incidence of FI is hard to evaluate 
and could in fact be even higher than reported.  
The commonest cause of FI is history of obstetric injury, which explains 
why the majority of the patients suffering from FI are female (Chatoor et 
al. 2007, Ruiz and Kaiser 2017, Ditah et al. 2014). Other causes such as neu-
rologic disease, inflammatory bowel disease, etc. can also contribute to the 
development of FI. The different causes of FI are listed in Table 1 (Ruiz and 
Kaiser 2017, Chatoor et al. 2007, Hayden and Weiss 2011). 
Table 1 Aetiologic factors contributing to FI  
Mechanism of FI Aetiologic factors 
Trauma Obstetric injury, sexual abuse, anorectal trauma 
Iatrogenic Internal sphincterotomy, fistulotomy, haemorrhoidectomy, low 
anterior resection 
Congenital Spina bifida, meningomyelocele, Hirschsprung’s disease, imper-
forate anus 
Neurologic Spinal trauma (other spinal pathologies), pudendal nerve atro-
phy, multiple sclerosis, diabetes mellitus 
Functional Crohn’s disease, ulcerative colitis, proctitis malabsorption syn-
dromes, chronic diarrhea, rectal prolapse/intussusception 
Anorectal diseases Haemorrhoidal disease, rectal prolapse, cancer 
2.3.2 Diagnosis of FI 
Since standards of hygiene, odors, etc. vary greatly among the general pop-
ulation, the quantification of the symptoms of FI is paramount in establish-
ing an adequate diagnosis. This can be facilitated by using specific symp-
tom severity scores. In addition, a thorough and detailed patient history 
will reveal the severity of FI and the impact it has on the individual’s qual-
ity of life.  
One of the first scores used to quantify the symptoms of FI was developed 
by Browning et al. This scoring system, though easy to use, was unable to 
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evaluate the severity of FI. It only assessed whether the patient was conti-
nent or not (Browning and Parks 1983). 
Currently the most commonly used incontinence scoring systems in Fin-
land and in Europe are the Wexner Incontinence Scale, alternatively 
known as the Cleveland Clinic Incontinence Score (Table 2), and the Vaizey 
score, also known as the St. Mark’s score. In addition of being easy to use, 
these questionnaires can help evaluate the severity of symptoms of FI and 
alterations in lifestyle due to FI (Vaizey et al. 1999, Jorge and Wexner 1993, 
Frudinger et al. 2003). 
Alternatively, the visual analogue score (VAS) can also be used to quantify 
FI symptom severity. Studies have shown the results of the VAS correlate 
well with specialised FI questionnaires. The VAS itself is not specific 
enough to replace specialised scoring tools (Paka et al. 2016, Devesa et al. 
2013, Hussain et al. 2014, Harvie et al. 2018). 
 
Table 2 The Wexner incontinence score (Jorge and Wexner 1993) 
Type of incontinence Frequency of incontinence 
 Never Rarely Sometimes Usually Always 
Solid stool incontinence 0 1 2 3 4 
Liquid stool incontinence 0 1 2 3 4 
Gas incontinence 0 1 2 3 4 
Use of pads 0 1 2 3 4 
Lifestyle alterations 0 1 2 3 4 
Sum of the points: 0- perfect continence; 20- total incontinence 
2.3.3 Treatment of FI 
There is a plethora of different treatment modalities for FI. The choice of 
treatment modality depends on the aetiology of FI and severity of symp-
toms. The treatment modalities specific to treatment of FI arising from 
OASI will be discussed in chapter 2.5.3 (Pages 39-42).  
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Treatment of FI starts by identifying the underlying cause of FI. Treatment 
of the underlying cause is essential in recovering optimum continence 
(Norton et al. 2007, Ruiz and Kaiser 2017). The initial treatment strategies 
of FI are conservative pharmacologic interventions as well as methods that 
address the dietary and behavioral aspects of bowel emptying. The goal is 
to slow down bowel motility and control the consistency of stools and 
times of bowel emptying (Figure 2) (Ruiz and Kaiser 2017, Bochenska and 
Boller 2016).  
 
Figure 2 General treatment algorithm of FI 
 
It has been shown that conservative treatment options such as dietary fibre 
supplementation decrease FI episodes (Forte et al. 2016, Paquette et al. 
2015). Once conservative treatment has been deemed unsuccessful, other 
more invasive procedures are considered. The different treatment options 
and their effectiveness are presented in Table 3.  
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Table 3 Treatment options of FI and their relative effectiveness (Forte et al. 2016, 
Ruiz and Kaiser 2017, Paquette et al. 2015) 
Type of intervention Effect on FI 
Dietary fibre supplementation Reduces FI episodes by 2.5 times, no effect on 
QoL 
Antidiarrheal medication Reduces FI episodes by 10-30%. Side effects 
such as abdominal pain and constipation  
Pelvic floor physiotherapy Pelvic floor physiotherapy alone is not effec-
tive in reducing FI episodes. Effective when 
used in conjunction with other conservative 
treatment options. 
Rectal irrigation Shown to resolve FI in up to 44% of patients 
(van der Hagen et al. 2012) 
Injectable bulking agents  No proven long-term efficacy. A minor effect 
on FI in the short term. 
Sacral neuromodulation Once implanted with a permanent stimulator 
51-100% of the patients experience complete 
continence.   
Posterior tibial nerve stimulation Up to 40% of patients have shown improved 
continence 
Sphincteroplasty A majority of patients experience a marked 
improvement of FI postoperatively. Conti-
nence deteriorates over time.  
End-colostomy All patients achieve total continence. 
2.3.4 FI and quality of life (QoL) 
The impact of FI on quality of life (QoL) is a clearly negative one. Patients 
with FI are often constrained to their homes and unable to work or move 
freely. In less drastic cases patients will need to map out their routes in 
order to have toilet facilities close by to avoid accidents (Ratto et al. 2012, 
Meyer and Richter 2015). FI also has a marked negative impact on sexual 
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function (Imhoff et al. 2012). Patients with FI tend to suffer more often from 
major depression, compared to the general population (Heymen 2004). 
Since the impact of FI on QoL is experienced differently by each individual, 
standardized questionnaires are helpful in quantifying the effect of FI on 
QoL (Bols et al. 2013). General QoL questionnaires, such as the SF-36 ques-
tionnaire, are not sensitive enough to register changes of QoL for specific 
conditions such as FI. Disease-specific questionnaires will yield a more spe-
cific result and should be used whenever possible (Rockwood 2004). The 
first FI-specific QoL tool developed, which is perhaps the most widely 
used, is the faecal incontinence quality of life index (FIQL). This question-
naire comprises of 29 questions and assesses the impact of FI on lifestyle, 
embarrassment, depression and behavior. The results of FIQL correlate 
well with incontinence scores such as the Wexner score (Bols et al. 2013, 
Meyer and Richter 2015).  The FIQL score cannot be used to evaluate treat-
ment success as it assesses only the impact of FI on QoL and not the sever-
ity of FI symptoms. Additionally, the FIQL questionnaire is rather cumber-
some to fill out, especially compared to the Vaizey and Wexner question-
naires, which limits its use in clinical practice (Bols et al. 2013). 
2.4 Obstetric anal sphincter injuries (OASI) 
2.4.1 Epidemiology of OASI 
The incidence of obstetric anal sphincter injuries (OASI) varies from coun-
try to country and is somewhat dependent on the traditions of obstetric 
care. 
There are numerous studies on the incidence of OASI. The reported inci-
dence varies and has been estimated to be as high as 11% of all births 
(Dudding et al. 2008b). More recent studies have revealed that the true in-
cidence of OASI is probably around 0.5–3% of all registered births. Inci-
dence of OASI is much higher among primiparous women (Laine et al. 
2009, Gurol-Urganci et al. 2013, Thiagamoorthy et al. 2014). The incidence 
of OASI has been steadily rising in Scandinavia and the UK in the past two 
decades. The reasons for this are unclear, but the rise could be attributed 
to increasing maternal age and birthweight of the children. Recent changes 
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in methods of preventing OASI have brought a slight decline in the inci-
dence of OASI in Sweden, Denmark, and Norway (Marschalek et al. 2018, 
Laine et al. 2009, Thiagamoorthy et al. 2014). 
Studies where women were evaluated postpartum with EAUS revealed 
that the incidence of OASI could be as high as 35% in all primiparas (Sultan 
et al. 1993). The incidence of OASI in Finland was 1.2% of all births regis-
tered in 2016. OASI was found to be around three times more common 
among primiparous women than in multiparas. The same study revealed 
OASI to be related to instrumental delivery (Heino et al. 2017). Other risk 
factors, such as Asian ethnicity, large birthweight, and prolonged second 
stage of labour, have also been associated with the development of OASI 
(Ramm et al. 2018, Smith et al. 2013a).  
2.4.2 Classification of OASI 
Perineal injuries can be classified according to severity into four degrees or 
grades, as described by Sultan et al. in 1999 (Sultan 1999a).  
The first-degree perineal tear involves only the perineal skin and vaginal 
mucosa.  
In second-degree tears the injury is constrained to the perineum involving 
perineal muscles but not the anal sphincters.  
A third-degree perineal tear involves the anal sphincter complex and is 
further subcategorised as a Grade 3a tear, where less than 50% of the thick-
ness of EAS is torn; a Grade 3b, where more than 50% of EAS thickness is 
torn; and a Grade 3c tear, where the tear involves the full thickness of the 
EAS and also the IAS, with the rectal mucosa intact.  
A fourth-degree tear involves the EAS, IAS, and the wall of the rectum. In 
a fourth degree tear the injury penetrates the anorectal mucosa.  
Both third- and fourth-degree tears involve the anal sphincters, and due to 
that are classified as obstetric anal sphincter injuries (Table 4).  
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Table 4 Grading of perineal tears, according to Sultan et al. 
Grade 1 Superficial tear of the vaginal mucosa 
Grade 2 Tearing of the vaginal mucosa and perineal muscles 
Grade 3 a Tear of EAS, with <50%of the muscle thickness involved 
Grade 3 b Tear of EAS, with >50%of the muscle thickness involved 
Grade 3 c Complete EAS and IAS tear 
Grade 4 Tear involving the rectal mucosa 
 
OASI can also manifest in the form of an occult injury. In the case of an 
occult injury, there is no clear perineal defect detectable postpartum or the 
injury is diagnosed as a second-degree tear. Occult sphincter injuries can 
be detected only by imaging studies. The incidence of this type of injury 
has not been studied thoroughly. Studies that have been conducted on the 
matter have revealed the incidence of occult sphincter injury to be from 
1.2% to 23% in all deliveries. Probably the true incidence of occult injury is 
well below 5% (Pinta et al. 2004b, Andrews et al. 2006, Fowler 2009). 
2.4.3 Risk factors for OASI 
The main risk factors for OASI are instrumental delivery (particularly for-
ceps delivery), high birthweight, primiparity, Asian ethnicity, and pro-
longed second stage of labour (Donnelly et al. 1998, Smith et al. 2013b, 
Staric et al. 2017, Rosen et al. 2015). A short perineal body has also been 
associated with an increased risk of OASI (Geller et al. 2014, Lane et al. 
2017). According to some researchers, the use of epidural analgesia also 
contributes to the development of OASI (Kapaya et al. 2015, Groutz et al. 
2011).  
The effect of mediolateral episiotomy on the incidence of OASI has been a 
matter of debate (Revicky et al. 2010, Dahl and Kjolhede 2010). A large reg-
istry-based study conducted in Finland found the incidence of OASI in-
creased as the rates of episiotomy declined (Raisanen et al. 2013b). Other 
studies have shown episiotomy to be a risk factor for OASI (Ramm et al. 
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2018). A Cochrane Review found there to be no evidence that routine epi-
siotomy will protect against perineal trauma. In selected cases, where in-
strumental delivery is anticipated, the use of episiotomy will help to pre-
vent severe perineal trauma. Routine use of episiotomy is not recom-
mended. In cases where there is no need for instrumental delivery, routine 
episiotomy will increase the risk of OASI (Jiang et al. 2017, Marschalek et 
al. 2018). 
2.4.4 Prevention of OASI 
The first documented technique for the prevention of obstetric tears was 
described by DeWees in 1889. It is known as the flexion technique.  The 
manoeuvre involves applying pressure on the foetal head, with one hand 
to maintain it in flexion until crowning. The other hand applies pressure to 
the perineum. 
In 1903 Ritgen described a manoeuvre where two fingers were placed in 
the anus of the woman. Simultaneous forward and upward pressure was 
applied to the foetus’s head between contractions. This manoeuvre was 
later modified by placing the two fingers on the perineum instead of in-
serting them in the anus (Cunningham 2008).  
A modification of the Ritgen’s manoeuvre
 
was described in 1976. The mod-
ified manoeuvre was performed during a contraction. There were no other 
differences between the modified manoeuvre and the original.  
The Finnish manoeuvre was described by Pirhonen et al. in 1998. In this 
manoeuvre, the speed of crowning is controlled by applying pressure on 
the head of the foetus. The first and second finger are then used to support 
the perineum while the flexed third finger is used to grip the foetus’s chin. 
After achieving control of the foetus’s chin, the woman is instructed to stop 
pushing and the midwife slowly delivers the foetus’s head manually 
through the perineal ring (Pirhonen et al.). 
Observational studies conducted in Scandinavia show that implementa-
tion of the Finnish method can reduce the incidence of OASI (Poulsen et al. 
2015). Most publications on these manoeuvres’ effects on the incidence of 
OASI have been large registry-based studies. A prospective randomised 
trial on the effectiveness of the Ritgen manoeuvre was unable to show any 
decrease in the incidence of OASI (Jönsson et al. 2008). 
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Focusing on risk factors associated with obstetric injury is of key im-
portance in reducing the incidence of OASI. Unfortunately, there are no 
measures available to completely prevent OASI from occurring during 
vaginal delivery (Kapaya et al. 2015, Räisänen et al. 2012).   
2.4.5 Primary diagnosis of OASI 
Diagnosis of OASI is done immediately postpartum. The vaginal tear is 
inspected and a rectal examination is performed. The postpartum assess-
ment must be carried out with proper lighting and anaesthesia, preferably 
in an operating room setting. The patient must be positioned in a way that 
the perineum is visible and accessed easily. Bleeding and oedema can make 
the primary diagnosis of OASI rather challenging (Samuelsson et al. 2000). 
Palpation of the sphincter muscles via the rectum is the single most im-
portant diagnostic tool in diagnosing sphincter lesions postpartum 
(Harvey 2015, Baghestan et al. 2010). The diagnosis of OASI requires expe-
rience. Training programmes on the detection of OASI have shown to in-
crease knowledge on the surgical repair of OASI. Currently there are no 
publications on the effect of these training programmes on treatment out-
comes of OASI (Vieillea et al. 2014, Zimmo et al. 2017, Patel et al. 2010). The 
use of EAUS immediately postpartum does not increase the accuracy of the 
diagnosis of OASI. The use of EAUS will help to identify occult anal 
sphincter injuries, which, as discussed earlier, can occur in up to 23% of 
vaginal deliveries (Pinta et al. 2004b, Andrews et al. 2006). In a Cochrane 
Review from 2015, the use of EAUS prior to repair of OASI was shown to 
improve continence outcomes (Walsh and Grivell 2015).   
2.4.6 Primary repair of OASI 
In Finland, the primary repair of OASI is conducted by a gynaecologist or 
a gastrointestinal surgeon. Regardless of the speciality of the attending 
physician, the repair of OASI requires experience or supervision by a phy-
sician experienced in the field. It is recommended that the primary repair 
of OASI be postponed if experienced personnel are unavailable. Postpon-
ing the repair up to 24 hours is acceptable and has no negative effect on the 
outcome (Dudding et al. 2008a). One study has even suggested that a delay 
of up to 72 hours will not have any negative long-term results compared 
to immediate repair; these result have not since been replicated (Soerensen 
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et al. 2008). Surgical repair of OASI must be conducted in operating room 
conditions, under adequate lighting and with proper instrumentation. The 
patient must be anaesthetised. Either general or epidural analgesia is rec-
ommended for the repair (Harvey 2015, Abdou and al 2007, Aigmueller et 
al. 2015).  
2.4.6.1 Technique 
It is currently recommended that when attempting a primary repair of 
OASI, the EAS must be sutured using the overlapping technique. This tech-
nique was first described by Parks and McPartlin (1971) for the secondary  
repair of sphincter defects. Later, this method was adopted to be used in 
the primary repair of OASI (Sultan 1999b) (Figures 3 and 4). If possible, the 
IAS must be approximated using interrupted stiches (Roos et al. 2010, 
Figure 3 Intraopera-
tive image of over-
lapping SP 
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Sultan 1999b). Studies have shown the overlapping technique to be supe-
rior to end-to-end suturing of the EAS (Rygh and Korner 2010, Lepisto et 
al. 2008, Fernando et al. 2013). 
The repair technique depends on the grade of the tear. In Grade 4 tears the 
anal mucosa is first repaired using rapidly absorbable interrupted sutures. 
Then the IAS is sutured, if identified, using interrupted 3-0 monofilament 
sutures. In Grade 3a sphincter injuries, the approximation of the torn 
sphincter muscles is sufficient. In Grade 3b and c injuries, an overlapping 
repair using 2-0 monofilament U-shaped sutures is recommended. The 
overlapping repair requires the mobilisation of the muscle fibres, so that a 
0.5–1cm overlap is achieved (Fernando et al. , Sultan 1999b, Williams et al. 
2006, Abdou and al 2007, Aigmueller et al. 2015, Temtanakitpaisan et al. 
2015). 
 
Figure 4 Schematic representation of the overlapping sphincteroplasty 
2.4.6.2 Suture materials 
There is scarce evidence on the effect of different suture materials on the 
outcome of the repair of OASI. Current guidelines recommend the use of 
slow absorbable sutures, such as polydioxanone (PDS) or polyglactin 
(Vicryl) (Harvey 2015, Abdou and al 2007, Aigmueller et al. 2015). These 
recommendations are based on a single randomised controlled trial com-
paring PDS with Vicryl in repairing OASI. The results of this trial showed 
no statistical difference in wound healing between the two suture materials 
(Williams et al. 2006).  
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2.4.6.3 Postoperative management 
Postoperative antibiotics have been shown to reduce the risk of wound 
complications after surgical repair of OASI (Buppasiri et al. 2014). There is 
no consensus on the duration of the antibiotic regime nor on which antibi-
otic should be prescribed. One randomised trial on the length of the anti-
biotic regimen post-OASI showed that a seven-day antibiotic treatment de-
creased perineal wound complications compared to a single dose of pre-
operative antibiotic prophylaxis (Duggal et al. 2008). 
 In Finland women diagnosed with OASI are prescribed an antibiotic regi-
men similar to the one described by Duggal et al. They receive intravenous 
antibiotics for the duration of the hospital stay, which is followed by a 
seven-day oral regimen after discharge.  
Laxatives should be prescribed to women with OASI to prevent unneces-
sary straining and pressure on the anal sphincter (Sultan 1999b). There 
have been no studies on the long-term effects of laxative use after the repair 
of OASI. A randomised controlled trial found that the use of lactulose after 
SP reduced the pain of the first bowel movement postpartum (Mahony et 
al. 2004a).  
Not prescribing laxatives or antibiotics after the repair of OASI can lead to 
the failure of primary SP. Lactulose is prescribed to all women following 
the repair of OASI in Finland.  
Most patients who have been diagnosed with OASI in Finland are referred 
to a physiotherapist for pelvic floor physiotherapy and biofeedback. There 
is little evidence on the effect of biofeedback therapy following OASI. Stud-
ies on the subject are mostly based on women with existing symptoms of 
FI and ROASI. It has been shown that biofeedback improves the symptoms 
of women with ROASI (Kairaluoma et al. 2004b, Mahony et al. 2004b), 
though a Cochrane Review from 2012 found neither biofeedback nor pelvic 
floor physiotherapy effective enough to be recommended as a sole treat-
ment modality for FI (Norton and Cody 2012). In a more recent Cochrane 
Review, pelvic floor physiotherapy alone was found to have no effect on 
the symptoms of FI postpartum (Woodley et al. 2017). Biofeedback therapy 
in conjunction with other treatment modalities, such as antidiarrhoeal 
agents and physiotherapy, may have a synergic effect in preventing symp-
toms of FI postpartum (Scott 2014).  
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2.4.7 Outcomes of the primary sphincter repair 
One of the reasons why evaluation of the treatment success of OASI is so 
challenging is the fact that the majority of women experience some form of 
incontinence postpartum. This has been attributed to pudendal nerve neu-
ropathy due to the nerve being subjected to shearing forces during vaginal 
delivery (Snooks et al. 1984). Usually, in the absence of OASI, these symp-
toms subside (Johannessen et al. 2018, Borello-France et al. 2006, Rusavy et 
al. 2016, Lo et al. 2010, Fonti et al. 2009). 
The short-term outcomes of the repair of OASI show that as many as 75% 
of women have a persistent sphincter defect detected on sphincter imag-
ing. About the same percentage of women have reported either FI or faecal 
urgency (FU) (Pinta et al. 2004a, Lohuis and Everhardt 2014). Gas inconti-
nence (GaI) can occur in up to 61% of patients (Pinta et al. 2004a). It would 
seem that the symptoms of incontinence subside over time. Medium-term 
results indicate that the incidence of FI and GaI after the repair of OASI is 
around 20–30% (Molander et al. 2007, Marsh et al. 2011, Dickinson et al. 
2013). This suggests that the symptoms of FI could indeed subside over 
time, though only a few studies on this matter have been published, with 
contradicting results (Barisic et al. 2006, Salim et al. 2014, Lo et al. 2010).  
FU seems to be a much more common symptom than FI, occurring in 35% 
of women after medium-term follow up (Marsh et al. 2011)  
Long-term follow-up of patients with OASI suggests that symptoms of in-
continence persist in 29–59% of women. Most of them complain of GaI and 
FU rather than FI. Studies where patients with OASI were compared to 
women without OASI revealed that 3–24% of the women in the control 
group also reported symptoms of FI (Samarasekera et al. 2008, Bharucha et 
al. 2012, Sundquist 2012).  
The symptoms of FI seem to be dependent on the initial severity of OASI. 
Patients with a more severe perineal tear are more likely to have longer-
lasting symptoms of FI. According to Jangö et al. (2017) women with a 
Grade 4 perineal tear had more expressed symptoms of FI than patients 
with Grade 3a and Grade 3b tears (Evers et al. 2012, Roos et al. 2010, Salim 
et al. 2014, Jango et al. 2017b, Barisic et al. 2006, Cornelisse et al. 2016, 
Soerensen et al. 2013, Sundquist 2012).   
In addition to poorer continence, women with a history of OASI reported 
suffering more from stress urinary incontinence, dyspareunia, and pain 
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during defecation (Marsh et al. 2011).  Although the effect of OASI on qual-
ity of life has yielded somewhat contradictory results, it can be said that 
OASI has a general and profound negative effect on the quality of life. Ac-
cording to studies conducted with healthy controls, up to 82% of women 
with a history of OASI reported deteriorated quality of life (Evers et al. 
2012, Cornelisse et al. 2016, Sundquist 2012, Tucker et al. 2013, Fodstad et 
al. 2016, Kumar et al. 2012, Palm et al. 2013, Raisanen et al. 2013a). Women 
with a history of OASI are reported to have deteriorated sexual function 
postpartum compared to healthy individuals (Visscher et al. 2014, Fodstad 
et al. 2016). A study by Fodstad et al. (2016) revealed that women with a 
history of OASI will postpone coitus longer than controls without OASI.  
2.4.8 Reasons for repair failure  
According to previously published research, up to 75% of women with a 
history of OASI have a persistent EAS or IAS defect detected upon imaging 
(Pinta et al. 2004a, Lohuis and Everhardt 2014). Long-term outcome studies 
have shown that only a fraction of women with a persistent sphincter de-
fect are in fact incontinent (Frudinger et al. 2008).  
The reasons for these poor outcomes can be dependent on the factors in-
fluencing the repair of OASI, such as the use of end-to-end repair instead 
of the overlapping technique, use of inappropriate suture materials, or fail-
ure to prescribe antibiotics and laxatives postoperatively.  
It has been shown conclusively that the use of the overlapping SP tech-
nique improves the primary outcomes of the repair (Rygh and Korner 
2010, Fernando et al.). The dissection of the EAS to facilitate the overlap-
ping repair may cause deinnervation of the muscle and contribute to a 
poorer functional outcome of the repair (Malouf et al. 2000a); however, ac-
cording to Fernando et al., patients who have undergone the overlapping 
primary SP have a slower deterioration of symptoms compared to those 
who have undergone an end-to-end SP (Fernando et al. 2013). 
As discussed earlier, the grade of the perineal tear on diagnosis seems to 
influence the functional outcome of primary SP. Due to more excessive 
bleeding and tissue damage, the severity of the tear has a direct influence 
on the complexity of the repair (Roos et al. 2010). Reasons for failure of 
primary SP have not been studied in great depth. Studies published on this 
matter to date have not been able to identify any patient-dependent factors 
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that could contribute to the failure of the primary SP (Glasgow and Lowry 
2012). 
It has been shown that proper diagnosis and treatment of OASI is essential 
in achieving adequate long-term continence. Following educational pro-
grammes, physicians have displayed better theoretical knowledge and a 
more adequate detection of OASI than before the training, but currently 
there is no evidence available on the effects of these programs on the out-
comes of OASI repair (Vieillea et al. 2014, Krissi et al. 2015).  
2.5 Residual obstetric anal sphincter injuries (ROASI) 
2.5.1 Definition 
Despite adequate repair of OASI, women with a history of such an injury 
can have defects of the anal sphincter detected on postpartum imaging 
studies. As discussed before, a small proportion of OASI can manifest as 
occult sphincter injuries, with no direct sphincter defect detected on post-
partum clinical examination (Pinta et al. 2004b, Andrews et al. 2006). 
In this paper, we will define these tears as residual obstetric anal sphincter 
injuries (ROASI). The aetiology of ROASI is heterogeneous: it involves 
women with missed OASI, occult OASI, and those who have undergone 
appropriate primary repair of OASI, but have a sphincter defect detected 
upon follow-up imaging.  
The repair of OASI can be defined as primary repair, which occurs imme-
diately postpartum, or secondary repair. The secondary repair occurs 
months if not years after the initial injury. Alternatively, secondary repair 
can be defined as repair of ROASI.  
2.5.2 Diagnosis of ROASI 
Diagnosis of ROASI is challenging. As discussed earlier, postpartum FI oc-
curs often and is not always caused by a sphincter injury. Evaluation of 
continence status using designated questionnaires at the maternal outpa-
tient clinic is usually the first modality of diagnosis. 
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The diagnosis of ROASI relies heavily on imaging of the anal sphincter 
musculature. Currently no method other than ultrasound or MRI has been 
able to adequately detect ROASI (Faltin et al. 2005, Sultan et al. 1994). There 
is a variation of ultrasound and MR imaging modalities available that can 
be used to image the anal sphincter complex. Each of these modalities has 
its own limitations. EAUS has been the gold standard for diagnosing 
ROASI; alternatively, MRI with either endoanal or endovaginal coils, ex-
ternal phased-array MRI, or transperineal ultrasound can be used 
(Eisenberg et al. 2018).  
Anorectal physiology testing is important in evaluating the neuromuscular 
function of the sphincter complex. Anal manometry (AM) and pudendal 
nerve terminal motor latency (PNTML) are the methods of choice for eval-
uating the contractile strength and the innervation of the anal sphincters 
(Dudding et al. 2008b, Roos et al. 2012).  
2.5.2.1 Clinical evaluation of ROASI 
The clinical evaluation of ROASI begins with the taking of patient history. 
It is important to retrieve a detailed obstetric anamnesis. History taking 
will give additional information on the severity of symptoms and the pa-
tient’s expectations of possible treatment outcomes (Dudding et al. 2008b, 
Sultan et al. 1994).  
Clinical evaluation of the perineum is essential in determining whether the 
patient has a patent rectovaginal fistula, which is a definite indication for 
SP and surgical closure of the fistula (Saclarides 2002, Hibbard 1978). Peri-
neal scarring and shortening of the perineal body can also be an indication 
of a possible sphincter lesion (Frudinger et al. 1997, Lane et al. 2017). 
Though it has been shown that palpation and clinical evaluation are not 
diagnostic in determining sphincter lesions, this will give the physician the 
first impression of sphincter tone and possibly even rule out sphincter in-
jury as the cause of FI. A well-conducted primary clinical evaluation will 
aid in the planning of further diagnostic procedures if necessary (Jeppson 
et al. 2012, Dobben et al. 2006).   
Patients over 50 years of age should also undergo colonoscopy to rule out 
possible adenomas or cancerous lesions of the colon and rectum. Presence 
of such lesions could affect planned treatment strategies for ROASI.  
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2.5.2.2 FI questionnaires and symptom scoring 
To facilitate adequate evaluation of the severity of symptoms, it is essential 
that the symptoms of FI be objectified. The use of standardised FI symptom 
scoring questionnaires is one of the means to achieve this. Standardised 
scoring can help to determine the severity of the symptoms of FI, which 
could be difficult for some patients to adequately verbalise. FI question-
naires can also help in identifying patients who require further imaging 
studies and possible surgical treatment.  
Some treatment modalities such as SNM rely on FI questionnaires to eval-
uate the feasibility and success of treatment.  
The commonly available scores were discussed earlier in chapter 2.3.2 
(Page 19). 
A study published by Frudinger et al. (2003) showed that the sensitivity of 
FI symptom severity questionnaires was 57.1% in detecting EAS defects. 
Though FI questionnaires cannot be considered a diagnostic tool per se, 
they can detect deterioration of FI symptoms and help guide and plan fur-
ther diagnostic studies. 
2.5.2.3 Endoanal ultrasound (EAUS) 
The first paper on the use of EAUS was published in 1989 by Law et al.  
The first EAUS images were two-dimensional. The length of the defect was 
determined by moving the probe manually along the anal canal  (Law et 
al. 1991, Law and Bartram 1989). Later developments saw the creation of 
3D EAUS, which is much less operator-dependent imaging modality and 
allows for post hoc evaluation of the images in multiple planes. These fea-
tures allowed for a more detailed evaluation of the structures of the anal 
canal (Gravante and Giordano 2008, West et al. 2005).  
Before the development of EAUS, there were no methods available for im-
aging the anal sphincters. Since its introduction EAUS has rapidly evolved 
to be the gold standard for diagnosing OASI (Solan and Davis 2013, 
Albuquerque 2015).  
The 3D EAUS imaging procedure is performed with the patient in the lat-
eral prone or the jack-knife position. The endoanal probe is inserted into 
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the anal canal, and after initiation of the imaging process, a rotating ultra-
sound transducer moves in the proximal-distal direction inside the probe 
to obtain images. Using specialised software, the 3D image of the anal canal 
is created in real time. Though this is a quick and reliable imaging modal-
ity, it can cause some discomfort to the patient during the insertion of the 
probe (Figure 5). The imaging procedure itself, depending on the type and 
manufacturer of the hardware, usually takes no more than a minute 
(Brillantino et al. 2015). 
 
Figure 5 3D EAUS device. The imaging probe is marked with an arrow 
3D EAUS imaging produces a volumetric cube (Figure 6), where the IAS 
appears as a hypoechogenic circular structure; the EAS in contrast appears 
as a hyperechogenic structure. 3D EAUS allows for the imaging of the anal 
canal, EAS, and the most cranial aspect of m. puborectalis (Abdool et al. 
2012). The levator plate and other aspects of the pelvic floor cannot be im-
aged using 3D EAUS (Gravante and Giordano 2008). 3D EAUS is unsuita-
ble for evaluating sphincter atrophy. A study by West et al. demonstrated 
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this convincingly (West et al. 2005). In the case of a rectovaginal fistula, 3D 
EAUS may be used to gain more information about the fistula tract.  
 
 
Figure 6 3D EAUS image of an anterior EAS defect (marked with a white arrow) 
2.5.2.4 Magnetic resonance imaging (MRI) 
The use of magnetic resonance to produce images of the human body was 
first described by Paul Lauterbur in 1973. In 2003 Lauterbur and Mansfield 
were awarded the Nobel Prize for the development of MRI. MR images are 
produced when the patient lies in a strong and static magnetic field. This 
magnetic field causes the alignment of all the hydrogen atoms or protons 
in the body. A radio frequency impulse is used to excite the protons, which 
then spin out of alignment. Different receiver coils are used to detect the 
energy released as the protons realign with the magnetic field. The im-
provement in MR image quality has been enormous in the past decade. 
Developments such as the introduction of high field-strength supercon-
ducting magnets and phased-array coils allow for the acquisition of very 
precise images of various tissues (Edelman 2014).  
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MRI was first used to image obstetric injuries in the 1990s (Aronson et al. 
1990). The quality of the earlier images did not allow for the imaging of the 
sphincter complex without endoanal coils. Studies comparing 3D EAUS 
and MRI with endoanal coils have shown that endoanal MRI is as precise 
as 3D EAUS in diagnosing EAS defects (Hussain et al. 1996). Some of these 
studies revealed 3D EAUS to be superior in detecting IAS defects (Tan et 
al. 2008a, Malouf et al. 2000b, West et al. 2005).  
External phased-array MRI has been found to be comparable to MRI with 
endoanal coils in detecting IAS and EAS lesions (Figure 7). A study com-
paring the two modalities found that there was no difference between them 
in the accuracy of detecting sphincter defects (Terra et al. 2005). 
 
Figure 7 MR image of an EAS defect. The defect is marked with an arrow 
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Though MRI performed using either the endoanal or the external phased-
array coils allows for the precise imaging of the anal sphincters, it is an 
expensive imaging method, especially compared to EAUS. Additionally, 
the imaging procedure is lengthy and cannot be performed on individuals 
with metallic implants, implanted electronic devices, or severe claustro-
phobia.  
2.5.2.5 Anal manometry  
Anal manometry (AM) is a useful tool for evaluating sphincter function. 
Previously, the standard method for evaluating sphincter function was wa-
ter perfused AM. This method gives an adequate estimate of the squeeze 
and resting pressures of the anal canal, though it is unable to identify the 
exact location of the low-pressure areas. Decreased squeeze pressure indi-
cates a defect in EAS function. A drop in the resting pressure usually indi-
cates a loss of function of the IAS (Corsetti et al. 2010, Pedersen and 
Christiansen 1989). Though AM is currently the method of choice for eval-
uating anal sphincter function, studies have not shown a clear connection 
between the decreased squeeze and resting pressures and the symptoms 
of FI (Roos et al. 2012, Nordenstam et al. 2010). 
Recent years have seen the development of AM hardware. Three-dimen-
sional high-resolution AM (3DHRAM) enables the evaluation of rectal 
pressures in more detail. Three-dimensional modelling of the pressure 
readings produces a pressure topogram of the anal canal (Lee et al. 2013). 
The pressure topogram allows for the localisation of low-pressure areas. 
The use of 3DHRAM has been proposed for the detection of sphincter de-
fects, though its accuracy is not comparable to 3D EAUS (Vitton et al. 
2013b, Vitton et al. 2013a). 
2.5.3 Treatment of ROASI 
The treatment of ROASI depends largely on the continence status of the 
patient. In Finland, the primary treatment of patients with ROASI is con-
servative medical treatment in combination with biofeedback therapy and 
pelvic floor physiotherapy. If patients are symptomatic immediately post-
partum or not responsive to conservative treatment, other more invasive 
treatment options are considered.  
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2.5.3.1 Conservative treatment 
The first line of treatment of patients with ROASI and symptomatic FI is 
conservative. The medical treatment regimen is comprised of antidiar-
rhoeal agents and dietary fibre supplements. Though no studies have been 
conducted exclusively on patients with ROASI, there is evidence that die-
tary fibre reduces the frequency of FI episodes. (Bliss et al. 2001). In a ran-
domised controlled trial conducted by Bliss et al. (2001), it was found that 
only supplements containing psyllium reduced the frequency of FI epi-
sodes.  
Antidiarrhoeal agents such as loperamide can also be used to treat FI. 
Loperamide is a synthetic -receptor agonist that is not resorbed in the 
bowel. Loperamide has shown to reduce episodes of FI. Treatment with 
loperamide can have notable side effects such as constipation and ab-
dominal pain (Omar and Alexander 2013, Norton et al. 2007).  
Rectal irrigation can also offer alleviation of the symptoms of FI. Studies 
have shown this method to have some effect in alleviating symptoms, but 
the effect is limited compared to more invasive procedures (Sturkenboom 
et al. 2018, Crawshaw et al. 2003). 
As discussed earlier the effectiveness of biofeedback and physiotherapy on 
FI is somewhat unclear. There have been studies published that show ef-
fectiveness of biofeedback therapy regardless of the presence of sphincter 
defects (Norton et al. 2003, Norton and Kamm 1999). The same authors 
later concluded in a Cochrane Review that there is insufficient evidence to 
advocate biofeedback therapy for FI (Norton and Cody 2012). A study of 
patients with a history of OASI showed a marked decrease in the Wexner 
scores after a period of biofeedback treatment (Ghahramani et al. 2016). A 
recent randomised trial, though not conducted on patients with ROASI, 
showed that the combination of physiotherapy, medical, and biofeedback 
treatment was effective in reducing symptoms of FI (Sjödahl et al. 2015).  
2.5.3.2 Sphincteroplasty 
Secondary SP for ROASI has been the gold standard of treatment for pa-
tients with sphincter defects and symptomatic FI (Fernando et al. 2006, 
McNicol et al. 2010). This mode of treatment has been challenged in the 
past decade by Sacral Nerve Modulation (SNM) treatment. 
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The technique of secondary SP was first described in 1971 by Parks et al. 
(Parks and McPartlin 1971). Repair of ROASI should be attempted no ear-
lier than 3 months from delivery (Barisic et al. 2006). The technique in-
volves the opening of the skin with a semi-circular incision above the sus-
pected injury site, which is usually anteriorly between the anus and the 
vagina. From there the sphincter defect is explored and the ends of the EAS 
dissected free of the surrounding tissues. If applicable and possible, the 
IAS defect is also explored. Usually the IAS cannot be identified intraoper-
atively. The EAS is repaired using the overlapping technique (McNicol et 
al. 2010). A diverting stoma is not recommended as it does not improve 
wound healing or the functional results of the secondary repair (Hasegawa 
et al. 2000). 
Outcomes of secondary SP have been somewhat disappointing. A system-
atic review on the matter published by Glasgow et al. concluded that the 
symptoms of FI in patients who have undergone secondary SP deteriorate 
over time (Glasgow and Lowry 2012). The reasons for these poor outcomes 
are unclear, although age has been suggested as one of the factors contrib-
uting to an unsatisfactory outcome. Results from studies published on this 
matter have been contradictory (Pinta et al. 2001, El-Gazzaz et al. 2012). 
Other studies have proposed atrophy of the EAS as a reason for a poor 
outcome of secondary SP (Briel et al. 1999).  
There are absolute indications for secondary SP, such as a patent rectovag-
inal fistula or other visible perineal defects (Saclarides 2002, Hibbard 1978). 
Currently, the mere presence of a sphincter defect detected upon imaging 
is not an indication for secondary SP. Recent evidence suggests that symp-
tomatic patients with a patent sphincter lesion have benefitted more from 
SNM treatment than from SP (Rodrigues et al. 2017).  
2.5.3.3 Sacral Nerve Modulation (SNM) Therapy 
The method of SNM was first described by Tanagho et al. in 1982. The 
method was first used for the treatment of urinary incontinence and reten-
tion (Tanagho and Schmidt 1982). Since then SNM treatment has estab-
lished itself as the first line of surgical treatment for FI (Goldman et al. 
2018).  
With the initial successful experiences of SNM treatment, the necessity of 
surgical sphincter repair has been questioned. If patients have a patent 
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sphincter defect detected upon imaging, SP prior to SNM treatment is not 
necessary. Studies have shown that a patent sphincter lesion does not affect 
the outcome of SNM treatment (Ramage et al. 2017, Boyle et al. 2009, 
Rodrigues et al. 2017, Noblett and Cadish 2014).  
The history, surgical technique, and outcomes of SNM treatment will be 
described in more detail below.  
2.6 Sacral neuromodulation therapy for faecal incontinence 
2.6.1 History 
The first SNM implantation was done by Tanango and Schmidt in 1982 in 
California. The method was initially described as an open technique, where 
an electrode was implanted adjacent to the sacral nerve root. Evaluating 
treatment feasibility requires testing patients with temporary SNM. The 
testing was initially conducted with a test electrode, which was explanted 
after test cessation regardless of the test outcome. Since then the implanta-
tion technique has evolved and currently uses a tined lead that is left in 
place after SNM testing and later used for permanent SNM. 
In 1995 a study was published by Matzel et al. describing the effects of 
SNM on the symptoms of FI. SNM was approved by the European drug 
administration in 1994 for the treatment of urgency urinary incontinence. 
Approval of the Federal Drug Administration (FDA) followed in 1997. In 
2010 the FDA approved the use of SNM for treatment of FI (Matzel et al. 
1995). 
The first SNM devices were implanted in Finland in 1996 for UI. The first 
implantation for FI was conducted in 1999. Since then there have been 
around 90 devices implanted in Finland annually (Kirss et al. 2018). 
2.6.2 SNM mechanism of action 
The exact mechanism of the effect of SNM on FI is unknown. There are 
several hypotheses of a possible mechanism of action.  
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S2-4 nerve roots are comprised of different nerve fibers: autonomic, so-
matic, efferent, and afferent sensory fibers. SNM has an effect on all of these 
fibers, with the most probable target being the large afferent sensory fibers. 
One possible mechanism of action might be the inhibition of a somatovis-
ceral reflex mediated by the afferent fibres. This results in a decreased co-
lonic motility and activation of IAS contractility. Though shown on animal 
models, this mode of action has not yet been conclusively proven in human 
trials (Dinning et al. 2007, Gourcerol et al. 2011, Vitton et al. 2008). A second 
possible mechanism of action is the activation of cortical centres associated 
with faecal continence control via afferent somatic fibres. Another sug-
gested mode of action could be the inhibition of the ascending defecation 
reflex via the same afferent fibres (Gourcerol et al. 2011, Amend et al. 2011).  
A study by Lundby et al. suggested that the mechanism of action of pro-
longed SNM treatment of at least two weeks could be associated with 
changes in the regions of the brain associated with learning. These changes 
are also mediated via the afferent fibres of the sacral nerve roots (Lundby 
et al. 2011).  
2.6.3 SNM implantation technique 
Currently SNM treatment relies on testing all patients with a temporary 
SNM. Studies have not been able to identify any predictive factors for the 
success of SNM treatment. Thus, a test phase is required to evaluate the 
feasibility of SNM treatment (Roy et al. 2014, Gourcerol et al. 2007). Prior 
to test phase initiation, the patient fills out all the relevant symptom sever-
ity questionnaires and keeps a diary of bowel habits and FI episodes for at 
least two weeks prior to test initiation.  
The implantation technique involves the implantation of a tined electrode, 
which stays in place after the test phase and can be removed in case of an 
unsuccessful test or used for permanent SNM if testing proved successful 
(Janssen et al. 2017). 
Currently the SNM implantation technique has been standardised and all 
centres in Finland use the technique described by Matzel et al. (2017). One 
of the key steps of this technique is the identification of the medial edge of 
the sacral foramina and the lower edge of the iliosacral junction. These 
landmarks are identified using intraoperative X-ray and marked on the pa-
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tient’s skin. This so-called H-marking facilitates the fast and easy identifi-
cation of the correct sacral foramina. (Matzel et al. 2017). After a needle is 
inserted into the sacral foramina, electrical current is passed along the nee-
dle to achieve a motor response of the pelvic floor. The desired effect is the 
“bellowing” of the pelvic floor upon stimulation with low-voltage electric-
ity. After confirming a satisfactory motor response, the electrode is im-
planted adjacent to the sacral nerve root which yields the best motor re-
sponse with the lowest voltage. Electrode implantation is then carried out 
using the Seldinger technique. The electrode is guided adjacent to the sa-
cral nerve root via a stylus under X-ray control.  
Implantation is followed by a test phase with a temporary stimulator. The 
test phase lasts 2-4 weeks, during which patients return to normal daily 
activities. They are asked to keep a diary of FI episodes during the test 
phase. At the end of the test phase, patients fill out once more the symptom 
severity scoring questionnaires. If there is a 50% reduction in either FI epi-
sodes or FI scores, the patient is eligible for permanent SNM implantation. 
The consensus of Finnish SNM specialists is that the patient’s subjective 
opinion of the treatment effect should also be taken into account when con-
sidering permanent SNM implantation.  This in effect means that upon 
careful consideration, some patients are implanted with permanent SNM 
without reaching a 50% reduction in FI symptoms during testing.  
2.6.4 Outcomes of SNM treatment for FI 
Matzel et al. (1995) were the first to report successful SNM treatment re-
sults for patients with FI. Since then, other authors have published similar 
short-term outcome results (Matzel et al. 1995, Melenhorst et al. 2007). A 
multicentre study published by Altomare showed that SNM treatment had 
lasting long-term effects on the symptoms of FI (Altomare et al. 2015). 
Wexner et al. were able to show in a small retrospective trial that the out-
comes of SNM were superior to secondary SP (Rodrigues et al. 2017).  
Evaluation of SNM treatment success is somewhat challenging. There is no 
universal measure how the test phase or final treatment success should be 
evaluated. Currently test phase success is determined by at least a 50% re-
duction in either FI episodes or specific FI severity scores (Goldman et al. 
2018). After implantation of a permanent device the same methods are 
used to objectify treatment success. QoL questionnaires may be used to 
evaluate SNM treatment’s effect on QoL, which requires obtaining baseline 
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values from patients prior to test initiation. QoL changes should be meas-
ured by specialised questionnaires, such as the FIQL. QoL scores are cum-
bersome to obtain, which is why their use is limited to clinical research 
(Bols et al. 2013).  
In a review article published in 2015, 13-88% (average 36.5%) of all patients 
tested for SNM implantation achieved total continence after permanent 
stimulator implantation (Mirbagheri et al. 2016). A much higher percent-
age of patients had a more moderate positive response (59-100%; average 
88%). Outcomes of this study are presented in more detail in Table 5 
Table 5 SNM treatment result for patients with FI (Mirbagheri et al. 2016) 
Study (year published) Sample size Partial responders (%) Total responders (%) 
Matzel et al. (1995) 3 3 (100%) 2 (67%) 
Vaizey et al. (1999) 9 8 (89%) 7 (78%) 
Ganio et al. (2001) 19 17 (89%) 14 (74%) 
Ganio et al. (2001) 25 22 (88%) 11 (44%) 
Leroi et al. (2001) 9 8 (89%) 1 (11%) 
Kenefick et al. (2002) 15 15 (100%) 11 (73%) 
Matzel et al. (2004) 37 37 (100%) 12 (32%) 
Leroi et al. (2005) 34 34 (100%) 5 (15%) 
Jarret et al. (2005) 59 46 (78%) 19 (32%) 
Kenefick et al. (2006) 19 19 (100%) 14 (74%) 
Oz-Duyos et al. (2008) 47 28 (59%) 14 (30%) 
Tjandra et al. (2008) 59 54 (91%) 25 (42%) 
Altomare et al. (2009) 52 38 (73%) 9 (17%) 
Boyle et al. (2011) 50 37 (74%) 8 (16%) 
George et al. (2012) 25 23 (92%) 12 (48%) 
Santoro et al. (2012) 28 28 (100%) 19 (68%) 
Hull et al. (2013)  72 64 (89%) 26 (36%) 
Oom et al. (2014) 46 37 (80%) 8 (17%) 
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SNM treatment has relatively low complication frequencies. The common-
est complications are pain and infection at the implantation site. A study 
by Bielefelt et al. (2016) found that 20% of the patients treated with SNM in 
the United States undergo additional surgery due to complications. Ex-
plantation of the SNM device because of infection occurs in 1.6–1.97% of 
cases (Lee et al. 2017, Myer et al. 2018, Bielefeldt 2016). 
SNM treatment has been shown to be successful in patients with patent 
sphincter lesions. The circumference of the sphincter lesion does not influ-
ence treatment outcome (Melenhorst et al. 2008, Chan and Tjandra 2008).  
Currently SNM is accepted as the first line of surgical treatment for FI in 
Europe (Goldman et al. 2018). 
The results of SNM treatment for patients with constipation and pelvic 
pain have not been comparable to treatment results for FI. Currently, the 
only official non-urologic indication for SNM treatment is FI (Thaha et al. 
2015, Tirlapur et al. 2013) 
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3 AIMS OF THE STUDY 
The aims of the present study were: 
1) To identify the risk factors for a failure of the primary repair of OASI.  
2) To compare external phased-array MRI to 3D EAUS imaging in di-
agnosing residual OASI.  
3) To assess the outcomes of SNM treatment for FI in the Finnish na-
tional cohort and determine factors that could predict treatment out-
come. 
4) To analyse the effect of a patent sphincter lesion or previous second-
ary sphincter repair on SNM treatment results. 
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4 MATERIALS AND METHODS 
This thesis consists of four papers based on three data sets. Study I is a 
retrospective study, based on data collected from Seinäjoki Central Hospi-
tal patient archives. Study II is a prospective study including patients from 
two Finnish central hospitals. Studies III and IV are based on a national 
data set collected from all centres in Finland that have provided or provide 
SNM treatment.  
The methodology of each study will be discussed below. Since studies III 
and IV are based on the same data set, the methods of these two studies 
will be described in the same chapter 
4.1 Factors predicting a failed primary repair of obstetric anal 
sphincter injury (study I) 
The data for this study was collected retrospectively from Seinäjoki Central 
Hospital patient archives. Data of all patients who had been diagnosed 
with OASI or had undergone secondary SP from 2004 to 2015 was col-
lected. Patients who had undergone imaging of the sphincter complex 
postpartum were selected for further analysis. Exactly 104 patients met the 
search criteria; of these 60 were included in the study (Figure 8).  
All patients included in the study had been followed up at two weeks post-
partum by a gynaecologist and at three months by a gastrointestinal (GI) 
surgeon. At the three-month follow-up, patients underwent imaging of the 
sphincters by either 3D EAUS or external phased-array MRI. Upon follow-
up, all patients filled out a Wexner incontinence questionnaire and were 
asked to evaluate the severity of their symptoms using the visual analogue 
score (VAS).  
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Figure 8 A diagram depicting the inclusion of patients (study I) 
The patients who met the inclusion criteria were divided into two groups: 
those with a successful primary SP and those with a failed primary SP. 
These two groups were compared for patient-dependent characteristics 
such as BMI, age, and parity. Also, delivery characteristics such as the use 
of episiotomy, instrumental delivery, use of pain relief during labour, med-
ical induction of labour, and lengths of different stages of labour were com-
pared between groups. Patients were also compared on the basis of types 
of SP and time from partum to SP. The time of day the repairs were under-
taken and by whom the repairs were conducted were also compared.  
The majority (n=58) of the women underwent 3D EAUS imaging of the 
sphincters. Two of the women were imaged using external phased-array 
pelvic MRI. Anal manometric studies were conducted using the water per-
fused pull-through technique. A total of 45 women were examined for 
squeeze and resting pressures. 
All patients in the failed primary SP group later underwent secondary SP 
conducted by a GI surgeon in Seinäjoki Central Hospital.  
Since the study in question was a retrospective register-based study, no 
approval of the ethical board was required. Permission to conduct the 
study was granted by the Chief Doctor of Seinäjoki Central Hospital.  
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4.2 External phased-array magnetic resonance imaging (MRI) in 
the diagnosis of obstetric anal sphincter injury (study II) 
Study II is a prospective study, which compares 3D EAUS and MRI in di-
agnosing ROASI. The study population was comprised of women who had 
given birth in Seinäjoki and Vaasa Central hospitals.  
An initial power analysis revealed that there was a strong correlation 
(r=0.788) between the results of the two imaging modalities. Initial power 
analysis indicated that 40 women would be needed to prove with a power 
of 90% that a moderate to strong (r>0.6) correlation exists between the two 
imaging modalities (Kirss et al. 2016).  
The first patients were enrolled in January 2014 and the study was termi-
nated in August of 2017 upon reaching 40 patients.   
4.2.1 Patients 
All women who had been diagnosed with OASI in Seinäjoki and Vaasa 
Central Hospitals were asked to participate in the study. Women with a 
suspicion of an undiagnosed OASI were also included in the study. Pa-
tients completed a Wexner incontinence questionnaire upon consenting to 
participate in the study. All women were followed up at 2 weeks and 3 
months postpartum by an obstetrician. All participants were imaged with 
MRI at least 3 months postpartum. Patients were followed up at least 8 
months postpartum by a GI surgeon; during this follow-up, the 3D EAUS 
study was conducted. Participants were informed of the MRI and 3D EAUS 
study results after the 3D EAUS imaging procedure. Women with symp-
toms of FI received biofeedback therapy and pelvic floor physiotherapy. 
When symptoms persisted after 6-8 weeks of physiotherapy, women were 
seen again by a GI surgeon for possible SP or SNM treatment.   
The 3D EAUS imaging was conducted by the two investigating GI sur-
geons. All images were analysed post hoc by both of the GI surgeons. The 
MRI images were analysed by two experienced radiologists, specialised in 
gastrointestinal radiology. The parameters analysed were: extent of the 
sphincter lesion, circumference of the tear in degrees and EAS thickness at 
different locations. The extent of the sphincter lesion, if present, was docu-
mented by patients having an isolated EAS or IAS defect or a combined 
EAS and IAS defect. The thickness of the EAS was measured at positions 3 
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and 9 on the proctologic clock face. This data was analysed for interrater 
reliability and intraclass correlation.  
4.2.2 Ethical aspects of study II 
Ethical approval was obtained from the Hospital District of Southwest Fin-
land Ethics committee (ETMK 66/1801/2015). The current study was regis-
tered in the ClinicalTrials.com portal, identification number NCT 
03039374. 
The ethical committee required the researchers to guarantee that all 
women would receive equal follow-up, regardless of their participation in 
the study. Women who declined to participate in the study would still have 
been followed up using the same protocol as described above, but the data 
from these investigations would not have been collected. All women who 
were offered the chance to participate in the study did so. 
4.3 SNM treatment results in patients with FI (studies III and 
IV) 
Studies III and IV are based on the Finnish national cohort of SNM patients. 
There are seven centres that offer SNM treatment in Finland. Data of all 
patients implanted from January 1999 to April 2017 with SNM for non-
urologic indications, such as FI, constipation, or pelvic pain, was collected 
from all centres that provide or have provided SNM treatment in Finland. 
Patient demographic data along with pre-implantation, SNM implanta-
tion, and follow-up data was collected from electronic patient archives 
from each of the participating centres. Data was analysed for possible fac-
tors that could influence the success or failure of SNM treatment.  
Data of patients who had been evaluated with EAUS or MRI were analysed 
for effects of a patent sphincter lesion or previous SP on SNM treatment 
outcomes. Patients who had been imaged previously were divided into 
groups according to imaging results. The first three groups included pa-
tients with an IAS defect, with an EAS defect, and with a combined IAS 
and EAS defect. The fourth group was formed of patients with normal 
sphincter musculature. The groups were compared for demographic data, 
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SNM implantation parameters and surgical procedure details, Wexner in-
continence scores, anal physiology test results, and aetiology of FI. Patients 
with a history of secondary SP were compared to patients with no history 
of SP for the parameters listed above.  
4.3.1 Evaluation of SNM treatment success 
All patients implanted with a permanent SNM device in Finland are fol-
lowed up at 1, 6, and 12 months postoperatively. After the 12-month fol-
low-up, patients are only followed up if problems occurred with the SNM 
device or the device needed servicing. Since there are no uniform evalua-
tion criteria used for the success of SNM treatment in Finland, universally 
applicable criteria for treatment success or failure was needed to analyse 
results. The success of the test phase was easily interpretable, with patients 
advancing to permanent stimulator implantation and unsuccessful tests 
ending with no implantation. Permanent SNM treatment was defined as 
successful when patients had a working permanent stimulator implanted 
with subjective alleviation of symptoms of FI. SNM treatment was deemed 
unsuccessful either when the SNM device had been explanted or the pa-
tient reported no subjective positive effect on symptoms of FI. 
4.3.2 Ethical aspects of studies III and IV  
Although these studies were retrospective, ethical approval from the Eth-
ics Committee of the Hospital District of Southwest Finland was obtained 
(ETMK: 163/1801/2015). The main ethical considerations of these studies 
were with the protection of sensitive personal data from multiple centres 
across Finland. Collection of patient data from multiple centres required 
additional approval from the governing body of each of the participating 
hospitals.  
4.4 Statistical analysis 
The statistical analyses of all of the studies were done in cooperation with 
the Turku Clinical Research Centres Department of Biostatistics. All pa-
tient data was analysed using Microsoft Excel for MAC version 15.13.1 and 
IBM SPSS software Version 23.  
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All continuous data was tested for normality using the Shapiro-Wilk test. 
Normally distributed data was analysed using the independent samples t-
test. The Mann-Whitney U or the Kruskal-Wallis independent samples 
tests were used to compare non-normally distributed data. Where indi-
cated, p-values were corrected using Bonferroni´s method. Either Pearson’s 
chi-squared test or the Fisher’s exact test was used to compare nominal 
values.  The interrater reliability was calculated using the intraclass corre-
lation (ICC) for continuous variables and Cohen’s kappa for categorical 
variables. The ICC values from 0.0 to 0.2 indicated a slight agreement, val-
ues from 0.21 to 0.40 a fair agreement, values from 0.41 to 0.60 a moderate 
agreement, values from 0.61 to 0.80 a substantial agreement, and values 
from 0.81 to 1.0 a perfect agreement (Hallgren 2012). Spearman’s correla-
tion coefficient was used to calculate correlations between ordinal data.  
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5 RESULTS 
5.1 Risk factors for developing ROASI (study I) 
A total of 60 women were included in the study, of whom 19 (31.7%) had 
a ROASI diagnosed with 3D EAUS or MRI upon follow-up. As discussed 
earlier, data of women with a ROASI (n=19) was compared to those with a 
successful primary repair (n=41) to determine the possible risk factors for 
developing ROASI. 
5.1.1 Demographic factors influencing the outcome of the primary repair 
There was no difference between the two groups in age or BMI of the 
women. Neither was there a difference in the demographic data of the chil-
dren. There was no difference in the length, weight, or head circumference 
between the children of the women in the two groups. The details of these 
findings are presented in Table 6.  
Table 6 The demographic data of the mothers and newborns in the ROASI and 
the successful primary SP group. 
 Successful primary SP ROASI  p-value 
 Mean (SD) Mean (SD)   
Age of women (years) 28.7 (4.2) 23.7 (5.9) 0.4071 
BMI3 of women (kg/m2) 23.1 (5.7) 22.8 (3.6) 0.7102 
Weight of the child 
(grams) 
3738 (425.9) 3646 (517.8) 0.4672 
Length of the child 
(mm) 
509 (19.8) 510 (22) 0.9342 
Head circumference of 
child (mm) 
352 (14.6) 353 (14.8) 0.7012 
1- Mann-Whitney U test, 2- two sampled T-test, 3- Body Mass Index of mothers measured before 
pregnancy 
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5.1.2 Risk factors contributing to ROASI 
Analysis of the two groups revealed possible risk factors that could con-
tribute to ROASI (Table 7).  
Table 7 Factors contributing to the failure of primary SP 
  Successful primary SP Failed primary SP p-value 
  n (%)  n (%) 
Fisher’s exact 
test 
Pain relief    
No pain relief 2 (4.9) 1 (5.9) 
0.003 
EA only 5 (12.2) 5 (29.4) 
PNB only 2 (4.9) 0 (0.0) 
N2O only 6 (14.6) 3 (17.6) 
EA and N2O 25 (61) 3 (17.6) 
EA, PNB and N2O 1 (2.4) 5 (29.4) 
Grade of tear    
Grade 3a tear 3 (7.3) 1 (5.9) 
0.563 
Grade 3b tear 22 (53.7) 6 (35.3) 
Grade 3c tear 14 (34.1) 3 (17.6) 
Grade 4 tear 2 (4.9) 2 (11.8) 
Tear repaired by:      
Specialist gynaecologist 18 (43.9) 5 (29.4) 
<0.001 
Specialist GI surgeon 23 (56.1) 6 (35.3) 
Gynaecology resident 0 (0.0) 2 (11.8) 
Midwife 0 (0.0) 4 (23.5) 
On-call repair 17 (42.5) 12 (75) 
0.039 Working hours repair 23 (57.5) 4 (25) 
Tear not recognized 0 (0.0) 6 (31.6) <0.001 
Overlapping SP 39 (95.1) 9 (47.4) 
0.025 
End-to-end SP 2 (4.9) 4 (21) 
Antibiotics prescribed  40 (97.6) 10 (62.5) 
<0.001 
Antibiotics not prescribed  1 (2.4) 6 (37.5) 
Laxatives prescribed 35 (85.4) 5 (31.3) 
<0.001 
Laxatives not prescribed 6 (14.6) 11 (68.8) 
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There was a higher number of women who were administered a combina-
tion of analgetics in the ROASI group, compared to the successful primary 
SP group (p=0.003). The majority of the tears in the successful primary SP 
group were repaired using the overlapping technique (p=0.025). The pri-
mary repairs in the ROASI group were more often conducted by a midwife 
or a specialising gynaecologist (p<0.001). There was a significant difference 
in the times of the repairs between the two groups. There were more re-
pairs undertaken during the on-call hours in the ROASI group, compared 
to the successful primary SP group (p=0.039). We found that the time from 
delivery to repair had no influence on the outcome of the primary repair 
(p=0.828). There was a significant difference in the use of postoperative an-
tibiotics and laxatives between the two groups. There was no difference in 
the incidence of postoperative infections between the two groups (p=0.696), 
although patients in the ROASI group were not prescribed antibiotics 
(p<0.001) nor laxatives (p<0.001) as often as in the successful primary SP 
group. There was no difference in the delay to initial repair between the 
two groups (Table 8).  
Table 8 Delay of initial repair of OASI. p-value calculated using the two-sampled 
t-test 
  Successful primary SP  Failed primary SP  p-value 
 Median (range) Mean (SD) Mean (SD)   
Delay to initial 
repair (h:min) 
01:30 (0- 123:56) 06:58 (3:43) 05:56 (02:25) 0.828 
 
As expected, the mean Wexner score was significantly higher in the ROASI 
group compared to the successful primary SP group (p<0.001). 
As expected, the maximum squeeze pressures were significantly lower in 
the failed primary SP group measured at 1 and 2 centimetres (Table 9). This 
is also the average length of the anal canal in females (Nivatvongs et al. 
1981). 
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Table 9 Anomanometric study results of the two groups 
 
Successful primary 
SP (n=30) 
Failed primary 
SP (n=15) 
p-value 
 Mean (SD) Mean (SD) 
Mann-Whitney U 
test 
Anomanometry findings    
Maximum squeeze pressure 
at 1 cm (mmHg) 
82.6 (30.6) 61.7 (31.5) 0.046 
Maximum squeeze pressure 
at 2 cm (mmHg) 
83.3 (34.9) 56.0 (28.9) 0.01 
Mean resting pressure at 1 
cm (mmHg) 
67.8 (30.3) 45.0 (26.2) 0.028 
Mean resting pressure at 2 
cm (mmHg) 
67.3 (33.9) 45.0 (26.2) 0.02 
    
5.2 Comparison of 3D EAUS and external phased-array MRI in 
the diagnosis of ROASI (study II) 
As per initial power analysis, 40 women were imaged with both 3D EAUS 
and MRI. The majority of the women participating were primiparous 
(n=25; 62.5%). The mean BMI of the women was 24.82 kg/m2 (SD: 4.729). 
The mean age at delivery was 29.97 years (SD: 4.386). The children born 
were mostly full term, with the median time of birth of 40+2 (range: 
37+0;42+6) weeks. The majority of the deliveries were spontaneous (n=21; 
52.5%). Nineteen of the deliveries were vacuum assisted. 
5.2.1 3D EAUS imaging results compared to MRI 
The mean time from delivery to MRI was 7 months 14 days (235.8 days; 
SD: 138.16 days). 3D EAUS was performed on average 7 months 1 day post-
partum (211.27 days; SD: 145.9 days; p<0.001). Details of the primary diag-
nosis of the OASI and immediate outcomes are outlined in Table 10.  
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Table 10 Results of the immediate diagnosis of OASI postpartum 
Grade of Tear  Grade 3A 13 32.5% 
Upon initial evaluation Grade 3B 20 50.0% 
 Grade 3C 5 12.5% 
 Grade 2 2 5.0% 
Repaired by Consultant Gynaecologist 22 55.0% 
 Consultant GI surgeon 12 30.0% 
 Resident Gynaecologist 3 7.5% 
 Midwife 3 7.5% 
Type of Sphincter Repair No repair 2 5.0% 
 Overlapping SP 20 50.0% 
 End-to-End SP 18 45.0% 
Antibiotic prophylaxis No antibiotic prophylaxis 5 12.5% 
 Antibiotic prophylaxis given 35 87.5% 
Complications postpartum No complications 31 77.5% 
 Wound infection 4 10.0% 
 Pain 2 5.0% 
 Pain & Wound infection 3 7.5% 
Incontinence postpartum No incontinence 22 55.0% 
 Gas incontinence 10 25.0% 
 Gas & Liquid stool incontinence 4 10.0% 
 Urge incontinence 3 7.5% 
 Solid stool incontinence 1 2.5% 
 
More EAS tears were detected with the MRI (n=15) compared to 3D EAUS 
(n=13). A moderate interrater reliability was observed between 3D EAUS 
and MRI in diagnosing the extent (κ=0.510) and the circumference (κ=0.506) 
of the EAS tear. Details of the imaging results are presented in Tables 11 
and 12. 
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Table 11 MRI and 3D EAUS findings on the extent of the sphincter injury 
 No tear IAS tear EAS tear IAS&EAS tear 
3D EAUS 
n 13 1 13 13 
% 32.5 2.5 32.5 32.5 
MRI 
n 10 2 15 13 
% 25 5 37.5 32.5 
Kappa1 0.510 
1-Interrater reliability value 
 
Table 12 MRI and 3D EAUS measurements on the circumference of the EAS, the 
size of the EAS defect in degrees, and the thickness of the EAS at position 3 and 
9 on the proctologic clock face 
 Tear in Deg. EAS thickness at 92 EAS thickness at 33 
MRI 
Mean 63.75 2.693 2.753 
St. Deviation 51.375 0.786 1.078 
3D 
EAUS 
Mean 48.11 2.698 2.838 
St. Deviation 38.901 0.794 0.762 
Kappa1 0.506 0.336 0.320 
1-Intra-class correlation value; 2-Position 9 on the proctologic clock face, right lateral as-
pect of the EAS; 3-Position 3 on the proctologic clock face, left lateral aspect of the EAS 
5.3 Predictive factors of SNM treatment outcome (study III) 
Study III is a national register-based study outlining the results of patients 
treated with SNM for FI in Finland. Additionally, we aimed to determine 
factors that could predict SNM treatment outcome. There were 701 SNM 
tests conducted for non-urologic indications in Finland from 1999 until 
April 2017.  A total of 462 patients were tested for FI.  
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5.3.1 SNM treatment results for FI 
There was sufficient data to conduct analysis of outcomes for 432 of the 462 
patients. The median time from SNM implantation to the time of data col-
lection was 858 days (2.4 years; range 8–4853 days). A total of 72.5% (n=313) 
patients had a successful SNM test outcome; 59.3% (n=256) of all the pa-
tients had a successful final treatment result. Explantation of the perma-
nent SNM device occurred in 13.1% (n=41) of the cases. Demographic data 
of patients is presented in Table 13.  
Wexner scores dropped significantly during the test phase from a median 
of 16 to 7. The Wexner scores remained low (median: 7.5) after permanent 
SNM implantation.  
 
Table 13 Demographic data of patients treated with SNM for FI. Distribution of 
patients having a successful test phase and final treatment outcome according to 
sex and age. 
 Overall (%) 
Successful test 
phase (%) 
p-value 
Successful final 
treatment result (%) 
p-value 
Median Age 62.9 64.4 0.813 64.5 0.466 
Male 68 (15.5) 33 (49.3) 
<0.001 
26 (38.8) 
0.637 
Female 368 (84.5) 280 (76.7) 230 (63.0) 
 
5.3.2 Predictive factors of SNM treatment outcome 
Analysis of the data revealed factors that could predict SNM treatment out-
come. The factors having a significant effect on SNM treatment outcome, 
such as aetiology of FI, are outlined in Table 14. Age had no effect on the 
SNM treatment outcomes. Sex of the patients did have a significant influ-
ence on the test phase outcome. A majority of the female patients (76.7%) 
had a successful test phase, whereas only 49.3% of the male patients expe-
rienced a successful test outcome. The sex of the patients had no effect on 
the final treatment outcome (p=0.637) (Table 13).  
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Table 14 Factors influencing SNM test phase and final treatment outcome. 
 Successful test 
phase (%) 
p-value 
Successful final treat-
ment outcome (%) 
p-value 
Aetiology of FI  
 
 
 
<0.001 
  
 
 
 
 
0.06 
  
Obstetric FI 82 (75.2) 69 (63.3) 
Idiopathic FI 89 (84.0) 80 (75.5) 
Iatrogenic FI 57 (57.6) 44 (44.4) 
Neurologic FI 50 (71.4) 36 (51.4) 
FI post rectal prolapse & 
other FI 
32 (72.7) 24 (54.4) 
 
Number of program 
changes during testing 
 
 
 
0.297  
 
 
 
0.053  
0 145 (72.9) 122 (61.3) 
1 42 (65.6) 38 (59.4) 
>1 25 (62.5) 17 (42.5) 
 
Number of working elec-
trodes during testing1 
  
 
 
 
0.031  
  
 
 
 
0.114  
4 139 (74.3) 122 (65.2) 
<4 68 (62.3) 54 (49.5) 
 
First motor response 
   
 
 
0.306  
<0.5V 198 (76.2) 
 
0.098  
167 
0.5-1V 61 (65.6) 47 
>1 54 (68.4) 42 
 
Complications during test 
phase 
 
40 (62.5) 
 
0.046 
 
33 
 
0.991 
Complications after stimu-
lator implantation 
- - 14 <0.001 
The cohort of patients with an OASI consisted naturally only of women. 
To evaluate whether in fact it was the sex of the patients, not the aetiology 
of FI, that influenced treatment outcome, the same analyses on treatment 
success were conducted excluding the patients with OASI as the aetiology 
of FI. We found that the when patients with OASI were excluded from the 
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analysis, only 48.5% of the male patients versus 76.7% of the female pa-
tients advanced to permanent SNM implantation (p<0.001). This indicated 
once more that sex of the patients has an effect on SNM test outcomes. 
Complications occurred in 15% (n=65) of the patients during the test phase 
and in 4.4% (n=19) of the patients after permanent SNM implantation. The 
different complications and their rates are presented in Figure 9. The com-
plications experienced during the test phase and after permanent SNM im-
plantation had a negative effect on the treatment outcome (Table 14). In 25 
cases the electrode was prematurely removed due to a complication during 
the test phase.  
 
Figure 9 The different complications during the test phase and after permanent 
SNM implantation (study III) 
A quadripolar tined lead was used for testing in the majority of cases 
(87.4%). A motor response from all of the four electrodes was a predictor 
of a successful test phase (p=0.031).  
5.4 SNM treatment outcomes in patients with a patent sphincter 
lesion or previous SP (study IV) 
In the Finnish national cohort of SNM patients, 237 had undergone EAUS 
imaging. The inclusion of patients in the study is outlined in Figure 10. 
Most of the patients included in the study were female (n=215; 91.1%). Not 
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surprisingly the commonest aetiology of FI was OASI, with 39.4% (n=93) 
patients having a history of obstetric injury. Of the patients included in the 
study, 73.1% (n=171) advanced to permanent SNM implantation and 60.6% 
(n=160) of the patients tested initially had a successful final treatment out-
come.  
 
Figure 10 Inclusion of patients in study IV 
5.4.1 EAUS findings in relation to SNM treatment outcome 
Patients who had undergone EAUS imaging were divided into four 
groups: patients with no sphincter damage, patients with an EAS defect, 
patients with an IAS defect, and patients with a combined EAS and IAS 
defect (see Figure 10). There were more women in the group with an EAS 
defect and in the group with EAS and IAS defect (p=0.008), compared to 
the group with IAS defect.  No other significant difference in the demo-
graphic data between the groups was noted. The Wexner scores dropped 
significantly during testing in all of the groups (p<0.001). The details of the 
Wexner scores are presented in Table 15. 
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Table 15 Median Wexner scores prior to testing and during the test phase. 
  
Median Wexner score before 
testing 
Median Wexner scores during 
testing 
Normal sphincters 15 7 
Pathologic EAS 15.5 10 
Pathologic IAS 17 14 
Pathologic EAS&IAS 16 6 
p-value 0.439 0.163 
P-values obtained using the single sample t-test 
 
The overall complication rate was 6.05%, with no difference between the 
rates of complications between the groups (p=0.194). The complications 
that occurred in different groups during testing are presented in Figure 11. 
 
Figure 11 Rates of different complications occurring during the test phase (St1) 
according to the EAUS finding (study III) 
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5.4.2 The effect of previous SP on SNM outcomes 
Of the 33 patients with previous SP, 2 had undergone a graciloplasty 
and 31 an overlapping SP. One of the patients was male. In 87.9% (n=29) of 
the cases, the indication for SP was ROASI; the rest of the patients had a 
history of iatrogenic injury. There was no significant difference in patients 
with or without previous SP in having a successful test phase (p=0.425) or 
final treatment outcome (p=0.442). Of the patients with previous SP, 78.8% 
(n=26) advanced to permanent stimulator implantation and 66.7% (n=22) 
patients had a successful final treatment outcome.  
Just over half of the patients (51.5%; n=17) with a history of previous SP 
had a patent EAS defect detected upon postoperative EAUS. 
64 Discussion 
6 DISCUSSION 
6.1 Risk factors for developing ROASI (study I) 
Research on OASI has mainly concentrated on the long-term outcomes of 
the primary repair and on the risk factors for developing FI after primary 
SP. There is less evidence on the reasons for the failure of primary SP. In 
this study, we analysed the data of women with a history of OASI to de-
termine the risk factors for developing ROASI. Previous studies have con-
firmed that a successful primary repair of OASI will yield better long-term 
results in regard to symptoms of FI compared to a secondary SP (Pinta et 
al. 2001, Barisic et al. 2006). In addition, a well-executed primary repair is 
cheaper per quality adjusted life year (QUALY) gained compared to sec-
ondary SP for ROASI (Tan et al. 2008b). 
The overall success of the primary repair was comparable to other, previ-
ously published results (Lohuis and Everhardt 2014, Molander et al. 2007). 
As described earlier, we found risk factors that could help reduce the inci-
dence of ROASI, the main one being the lack of expertise in diagnosing 
OASI, which will inevitably lead to treatment decisions based on inade-
quate information and to poorer treatment results. The results of this study 
were in line with previously published research, which has suggested that 
the delay of the primary SP of up to 24 hours has no effect on the outcome 
of the repair. In fact, repairs conducted during on-call hours seemed to be 
a risk factor for developing ROASI. Some studies have shown that the in-
volvement of experienced colorectal surgeons in the primary repair pro-
cess can benefit the outcome of the primary SP (McNicol et al. 2010, Krissi 
et al. 2015). In unclear cases, postponing the repair until experienced per-
sonnel are available will yield a more favourable outcome of the primary 
SP. Most of the injuries were diagnosed as grade 3B injuries; our data was 
not sufficient to indicate whether this was dependent on the lack experi-
ence of the attending physician in diagnosing OASI or due to the fact that 
grade 3B injuries are just most common. Results from study II indicate that 
grade 3B tear is probably the commonest type of OASI (see Table 10). It 
must be emphasised that an adequate diagnosis of OASI immediately post-
partum is the of the utmost importance in achieving a successful repair. 
Failure to diagnose OASI will lead to wrong treatment choices and a poor 
end result. Another factor contributing to an unsuccessful outcome of the 
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primary repair was failure to prescribe antibiotics and laxatives postoper-
atively.  
The Wexner scores were higher in patients with ROASI. There are studies 
that have indicated a correlation of Wexner scores with EAUS findings 
(Norderval et al. 2012). This suggests that FI questionnaires could be used 
as a primary diagnostic tool for the evaluation of ROASI.  
As this was a single centre retrospective study, it had all the limitations of 
such a study, the main one being the heterogeneity of data quality. This 
study also highlighted that even though there are guidelines for the follow-
up of patients with OASI, adherence to these guidelines was poor. All 
women diagnosed with ROASI were offered secondary SP as a treatment 
option. All of the women offered secondary SP underwent the procedure. 
6.2 External phased-array MRI in diagnosing ROASI (study II) 
This was a prospective study evaluating external-phased array MRI in di-
agnosing ROASI. Since its development, the gold standard of imaging the 
sphincter musculature has been the EAUS (Albuquerque 2015, Solan and 
Davis 2013). Though this is an easy and well tolerated method of imaging, 
it requires specialised hardware that is not readily available in all centres. 
The availability of 3D EAUS is particularly scarce in Finland. MRI hard-
ware, on the other hand, is widely available, though the availability of spe-
cialised endoanal coils can be limited. Unlike 3D EAUS, the acquisition of 
MRI can be lengthy, and the endoanal coil can be difficult for patients to 
tolerate. Since clinical evaluation alone is not precise enough in evaluating 
sphincter defects, diagnosis of ROASI must rely on imaging studies 
(Jeppson et al. 2012, Dobben et al. 2006). 
Studies comparing the diagnostic accuracy of endoanal MRI and 3D EAUS 
have concluded the two imaging modalities to be comparable in diagnos-
ing sphincter lesions (Terra et al. 2006, Stoker 2008, Briel et al. 1999, Tan et 
al. 2008a). Previous research has shown endoanal MRI to be as sensitive as 
3D EAUS in diagnosing EAS lesions, but 3D EAUS to be more accurate in 
diagnosing IAS lesions (West et al. 2005, Tan et al. 2008a, Deutekom et al. 
2007). We are unaware of any previous studies having been published 
comparing 3D EAUS to external phased-array MRI. 
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Results of the current study found that external phased-array MRI is more 
precise in detecting EAS lesions compared to 3D EAUS. 3D EAUS was un-
able to differentiate scar tissue from viable muscle fibres. As shown in pre-
viously published research, scar tissue interferes with normal muscle con-
tractility and may result in symptoms of FI (Terra et al. 2006). Results of 
this study indicate that external phased-array MRI is a valuable diagnostic 
tool in diagnosing EAS defects and is suitable for diagnosing ROASI. These 
results are similar to those published previously when comparing 3D 
EAUS and endoanal MRI results (West et al. 2005, Malouf et al. 2000b, 
Deutekom et al. 2007). 
The increased sensitivity of external phased-array MRI compared to 3D 
EAUS could lead to the overdiagnosis of ROASI (Thomas et al. 2017). This 
may very well be, but as currently only patients with symptoms of FI are 
allocated for surgical treatment detecting more sphincter lesions will not 
increase the number of patients being treated unnecessarily. Additionally, 
previously presented evidence supports secondary SP to be reserved for 
patients with a short time from initial injury. Results of our study suggest 
that young, symptomatic patients with a recent history of OASI should un-
dergo imaging of the anal sphincters. These patients could still benefit from 
a secondary SP (Pinta et al. 2001, Wald et al. 2014, Chatoor et al. 2007). 
This study was limited by the absence of a control group of healthy indi-
viduals.  
6.3 Results of SNM treatment for FI (study III) 
This study was the largest of its kind and the first analysing SNM treatment 
results in a national cohort. Our results were comparable with results pub-
lished earlier (Gallas et al. 2011, Leroi et al. 2011, Michelsen et al. 2010, 
George et al. 2012, Altomare et al. 2015). 
6.3.1 Predictive factors for SNM treatment outcome 
As discussed earlier, SNM treatment has become the first line of surgical 
treatment for patients with FI. There have been numerous studies pub-
lished on the short- and long-term results of SNM treatment. The predic-
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tive factors influencing treatment outcome have been less extensively stud-
ied (Hull et al. 2013, Mellgren et al. 2011, Hetzer et al. 2006, George et al. 
2012, Altomare et al. 2015, Gallas et al. 2011, Roy et al. 2014, Dudding et al. 
2008a). 
The results of our study indicate that there are factors that influence SNM 
treatment outcome. A novel finding of this study was the influence that 
patient sex and the aetiology of FI had on the SNM treatment outcomes. 
Male patients had considerably worse test phase outcomes compared to 
female patients. There was no obvious reason for this outcome. The differ-
ent aetiologic profile of male patients did not contribute to this finding; 
when patients with OASI were discarded from the analysis, male patients 
still had poorer test phase outcomes compared to females. There was no 
difference between male and female patients in the final treatment out-
come. This finding does not suggest that male patients should be deferred 
from SNM treatment, but is definitely a subject for further research.  
There was a disproportionally large number of patients with idiopathic FI. 
This group of patients was mostly female and probably had a history of 
obstetric injury.   
Previously published studies have not shown aetiology of FI to influence 
treatment results (Hull et al. 2013, Mirbagheri et al. 2016, Dudding et al. 
2008a, Roy et al. 2014). Results of this study seem to indicate the opposite. 
Aetiologic factors seemed to influence treatment outcome. Patients with a 
history of iatrogenic sphincter injury experienced worse treatment results 
compared to patients with other aetiologies of FI. When looking at the dif-
ferent types of iatrogenic injuries treated with SNM, including low anterior 
resection syndrome, post haemorrhoidectomy, and post fistulotomy FI, 
there was no difference in treatment outcomes between the groups. Since 
patients with OASI had considerably better treatment results, it would 
seem that a sphincter injury per se does not influence SNM treatment out-
come. Since currently there is no other method for reliably predicting the 
SNM treatment outcome other than performing the test phase, it not feasi-
ble to deny SNM treatment to patients with iatrogenic injuries. These re-
sults indicate that patients with an iatrogenic injury should be informed of 
the poorer outcomes.  
Contrary to some previously published studies, age did not seem to influ-
ence the outcome of SNM treatment (Govaert et al. 2009, Roy et al. 2014). 
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Cognitive function does play a role in selecting patients for SNM treat-
ment. Patients are required to give adequate feedback about the effects of 
sacral nerve stimulation and be able to operate the patient controller. Our 
results indicate that age should not be a limiting factor for initiating SNM 
treatment, if the patient has adequate cognitive function.  
The only stimulator dependent variable having a predictive value for treat-
ment success was the number of electrodes in the quadripolar lead provok-
ing a motor response. The number of responding electrodes is a clear indi-
cation of how the electrode is in contact with the nerve root, so it is not 
unexpected that this factor could influence treatment outcome (Elkelini et 
al. 2012, Su et al. 2017). 
Another factor influencing treatment outcome were complications occur-
ring either during the test phase or after permanent device implantation. 
The commonest complication was the infection of the operation site; the 
rates of complications were comparable to earlier published data (Lee et al. 
2017, Noblett et al. 2017). Proper anti- and aseptic precautions must be 
taken to reduce the possibility of infection. In addition, all Finnish centres 
administer preoperative intravenous antibiotics, continued by a seven-day 
oral regimen. The data of this study was insufficient to draw any conclu-
sions on which antibiotic regimen would be best to avoid complications. 
Results of this study suggest that aiming to reduce rates of complications 
can have a positive effect on SNM treatment outcomes.   
The limitations of this study were characterised by its retrospective nature. 
The main limitations were the lack of data on postoperative symptom spe-
cific scoring and the fact that there is no uniform method in Finland for 
detecting a 50% improvement in symptoms of FI. This forced us to opt for 
defining the test phase and final treatment success as described above (see 
4.3.1; page 50).  
6.4 The effect of sphincter lesions and previous SP on SNM 
treatment results (study IV) 
As with study III, this was the first study published on the effects of sphinc-
ter lesions on SNM treatment outcome in a national cohort. This study fea-
tures a large cohort of patients who have undergone EAUS imaging prior 
to SNM treatment. As this was a retrospective study, it has its limitations. 
The limitations of this study are similar to the limitations of study III. The 
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main one being the lack of uniform criteria for evaluating test phase and 
treatment success.  
As reported in previously published smaller studies, a sphincter lesion de-
tected upon EAUS imaging had no effect on the outcome of the test phase 
or final treatment outcome (Boyle et al. 2009, Ramage et al. 2017). Though 
EAUS imaging is well tolerated and not associated with any adverse ef-
fects, it is not widely available in Finland. Results of this indicate that im-
aging studies prior to SNM treatment initiation are not necessary, because 
they do not influence treatment outcome. 
As discussed earlier the outcomes of secondary SP have not been encour-
aging (Engel et al. 1994, Bravo et al. 2004, Nikiteas et al. 1996, Sitzler and 
Thomson 1996, Pinta et al. 2001). There is no compromise among research-
ers on the effectiveness of the secondary SP compared to SNM treatment 
(Altomare 2010, Goetz and Lowry 2005). Though data on the matter has 
been contradictory, there is evidence of SNM yielding better results com-
pared to SP, particularly in a situation when the delay from initial injury is 
years or even decades. A small study conducted by Rodrigues et al. (2017) 
revealed SNM treatment to be superior to SP in the short term. The results 
of the current study found previous SP to have no effect on SNM treatment 
outcome. This finding supports the treatment of patients with a patent 
sphincter lesion primarily with SNM, though it must be mentioned that the 
basis of an adequate continence postpartum lies in a well-executed primary 
repair of OASI (Kairaluoma et al. 2004a).  
The results of this study indicate that previous SP or a patent sphincter 
lesion have no effect on SNM treatment outcomes.  
6.5 Future aspects 
The results of these studies outlined some of the problems of treating pa-
tients with FI due to a history of OASI. One of the main questions raised 
was the indication of a secondary SP. As mentioned above, successful pri-
mary repair of OASI is paramount in achieving good long-term results. 
Currently it is unclear which patients, if any, should be treated with sec-
ondary SP and what the optimal timing is for SP. Is secondary SP a relevant 
treatment modality in the age of SNM? SNM treatment is very expensive, 
compared to a simple SP.  It could be argued that a secondary SP will post-
70 Discussion 
pone the symptoms of FI, but will these patients achieve long-term conti-
nence without SNM? The answer to these questions is subject to future re-
search.  
The results of studies III and IV also highlighted the need for a centralised 
database of patients treated with SNM. 
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7 CONCLUSIONS 
1) There are clear risk factors for the failure of the primary repair of 
OASI, such as inexperience of the attending physician, repairs con-
ducted during on-call hours, and use of improper suturing tech-
niques. Excessive use of pain medication during labour and failure 
to prescribe antibiotics and laxatives postoperatively can also con-
tribute to the failure of the primary repair.  
2) External phased-array MRI is a feasible imaging modality for imag-
ing patients with suspected anal sphincter injuries. MRI is as precise 
as 3D EAUS in detecting EAS lesions. MRI also facilitates the differ-
entiation of scar tissue from viable muscle fibres.  
3) Outcomes of Finnish SNM treatment results are comparable to pre-
viously published results. Patient sex and aetiology of FI have an in-
fluence on SNM treatment outcomes. 
4) Neither a patent sphincter lesion nor previous secondary sphincter 
repair has an effect on SNM treatment results.  
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Appendix 1: Wexner questionnaire and VAS used in Study II 
 
 
 
 
 
 
 
ULOSTEEN PIDÄTYSKYVYN ARVIOINTI 
 
 
Nimi: ______________________  Päivämäärä: ______________ 
 
 
 
 
INKONTINENSSIN TYYPPI ei koskaan harvoin joskus usein aina 
 
Karkaako kiinteä uloste?/ Tuleeko isoja 
vahinkoja? 
0 1 2 3 4 
 
Karkaako uloste, kun se on löysää? 0 1 2 3 4 
Karkaako ilma? 0 1 2 3 4 
Käytättekö vaippaa/sidettä tämän takia? 0 1 2 3 4 
Rajoittaako vaiva harrastuksia tai 
sosiaalista elämää? 0 1 2 3 4 
Karkaako virtsa yskiessä, hyppiessä, 
nauraessa tai ponnistaessa? 0 1 2 3 4 
PISTEET YHTEENSÄ  
 
 
 
harvoin = alle kerran/kuukausi  usein = kerran tai useammin/viikko 
joskus = yli kerran/kuukausi  aina = joka päivä 
 
 
Kuinka isoa haittaa koet 1-10 ulosteenkarkailusta? 
 
 
                            1…….2…….3…….4…….5…….6……..7……..8…….9…….10 
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Utvärder ing av avför ingsinkontinens 
 
 
Namn: ______________________  Datum: ______________ 
 
 
 
 
INKONTINENSTYP aldrig sällan ibland ofta alltid 
 
Läcker fast avföring?  
Händer ”stora” olyckor? 
0 1 2 3 4 
 
Läcker avföringen om den är lös? 0 1 2 3 4 
Läcker det luft? 0 1 2 3 4 
Använder du blöja/skydd för det här? 0 1 2 3 4 
Begränsar besvären ditt sociala liv/dina 
hobbyer? 0 1 2 3 4 
Läcker urin när du hostar, hoppar, 
skrattar eller anstränger dig? 0 1 2 3 4 
POÄNG SAMMANLAGT  
 
 
 
sällan = under en gång/månad  ofta = en eller flera gånger/vecka 
ibland = mer än en gång/månad alltid = varje dag 
 
 
Hur stort besvär förorsakar avföringsinkontinens 1-10? 
 
 
                            1…….2…….3…….4…….5…….6……..7……..8…….9…….10 
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Appendix 2:  Consent forms filled out by women participating in Study II 
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VASA CENTRALSJUKHUS, Kirurgiska kliniken 
Sandviksgatan 2-4 
65100 VASA 
Tel. (06) 323 1111 
E-mail: jaan.kirss@utu.fi 
 
SAMTYCKE TILL UNDERSÖKNING 
Passar sig en magnetundersökning av bäckenbotten för att konstatera sfinkterskada uppkommen 
under en förlossning 
 
Jag har fått information rörande ovannämnda undersökning och jag har läst den skriftliga patientin-
formationen, där undersökningens syfte, karaktär och de undersökningsmetoder som används är 
förklarade.  
  Jag har haft möjlighet att ställa frågor till undersökarna angående undersökningen och deltagandet 
i den samt få svar på mina frågor. 
   Man har förklarat för mig att de uppgifter som insamlas i undersökningen behandlas konfidenti-
ellt. Vid presentation och offentliggörande av undersökningsresultat avslöjas inte undersöknings-
personens identitet i något skede. 
  Jag samtycker frivilligt till att delta i undersökningen, i vilken man förklaras vilket sätt de påver-
kar livskvalitet och hur magnetundersökning passar sig för att konstatera sfinkterskada. Jag vet att 
om jag vill kan jag annullera mitt samtycke när som helst utan att uppge orsak och mitt avböjande 
inverkar inte på min rätt att få den medicinska behandling som jag är i behov av. 
 
Jag bekräftar att jag har fått patientinformationen samt en kopia av detta mitt mottagna samtycke. 
 
Samtyckesgivare Datum Underskrift 
Förnamn Efternamn 
Personsignum Adress 
Postnummer Postanstalt 
Tel. hem/arbete Mobiltel. 
Mottagare av 
samtycke 
Datum Underskrift 
Titel/yrke 
 
Namnförtydligande 
 
Tel. 
(06)- 323 1111 
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Appendix 3: Information for patients asked to participate in Study II 
 
 
Tiedote tutkittavalle (synnytyksen yhteydessä sulkijalihasvaurion saaneille) 
Sopiiko lantiopohjan magneettitutkimus (MRI) synnytykseen liittyvän peräaukon sulkijalihasvaurion 
toteamiseksi? 
Teitä pyydetään mukaan tutkimukseen, jossa tutkitaan peräsuolen sulkijalihasvaurioihin liittyvää 
ulosteenkarkailua. Soveltuisitte mukaan tutkimukseen, koska Teillä on synnytyksen yhteydessä todettu repeämä 
ja sen yhteydessä on vaurioitunut muun muassa peräaukon sulkijalihakset. Tämä tiedote kuvaa tutkimusta ja 
Teidän osuuttanne siinä.  
Osallistuminen tähän tutkimukseen on täysin vapaaehtoista. Voitte kieltäytyä osallistumasta tutkimukseen tai 
milloin tahansa keskeyttää osallistumisenne syytä ilmoittamatta.  
Saamanne hoito ei ole riippuvainen osallistumisestanne tutkimukseen.  
Lukekaa rauhassa tämä tiedote. Jos Teillä on kysyttävää, voitte olla yhteydessä tutkijalääkäriin tai tutkimuksen 
muuhun henkilökuntaan. Jos päätätte osallistua tutkimukseen, pyydämme Teitä allekirjoittamaan liitteenä olevan 
suostumuslomakkeen sekä kyselykaavakkeet. 
Taustaa 
Alatiesynnytykseen voi usein liittyä emättimen tai jopa peräsuolen sulkijalihaksen repeämiä. Repeämän 
vaikeusaste määritellään gynekologin toimesta heti synnytyksen jälkeen ja yleensä gynekologi tai 
vatsaelinkirurgiaan erikoistunut kirurgi korjaa repeämän saman tien. Noin 3-6 kk:n kuluttua synnytyksestä Teille 
järjestetään vatsaelinkirurgian poliklinikalla jälkikontrolli, jossa tarkastetaan miten sulkijalihasten korjaus on 
onnistunut. 
Vaikka repeämä olisi korjattu parhaalla mahdollisella tavalla, voi peräsuolen sulkijalihasrepeämän saanut kärsiä 
ulosteen pidätysongelmista. Oireet voivat olla lieviä, kuten ilman karkailua tai vaikeampia, kuten kiinteän 
ulosteen karkailua. Oireet saattavat ilmaantua vasta myöhemmin, vuosien jälkeen. 
Tutkimuksen tarkoitus 
Tämän tutkimuksen tavoitteena on selvittää, miten peräaukon sulkijalihasrepeämän oireet vastaavat 
magneettikuvien, ultraäänikuvien ja peräaukon painemittausten löydöksiin. Tämän lisäksi tutkittavia pyydetään 
arvioimaan, miten sulkijalihasrepeämä on vaikuttanut elämänlaatuun ja ulosteen pidätyskykyyn.   
Tämän tutkimuksen toteuttavat Vaasan ja Seinäjoen keskussairaalat yhteistyössä Turun Yliopistollisen sairaalan 
kanssa. Tutkimuksen rekisterinpitäjä on Vaasan keskussairaala, joka vastaa tutkimuksen yhteydessä tapahtuvan 
henkilötietojen käsittelyn lainmukaisuudesta. 
Tutkimuksen kulku  
Teille lähetetään postitse tiedote tutkimuksesta, kyselylomakkeet ja kirjallinen suostumuslomake.  Mikäli 
haluatte osallistua tutkimukseen, pyydetään Teitä palauttamaan täytetyt kyselylomakkeet ja kirjallinen 
suostumus allekirjoitettuina tutkijalääkäreille.   
Kun olette allekirjoittaneet suostumuksenne, Teille lähetetään aika lantionpohjan MRI-tutkimukseen, peräaukon 
sulkijalihasten painemittaukseen ja kirurgian poliklinikalle vatsaelinkirurgin vastaanotolle. Mikäli ette suostu 
osallistumaan tutkimukseemme, lähetetään Teille pelkästään aika kirurgian poliklinikalle. 
Kirurgian poliklinikalla tapaatte tutkijalääkäri Tarja Pinnan tai Jaan Kirssin. Poliklinikkavastaanotolla Teille 
tehdään myös peräsuolen sulkijalihasten ultraäänitutkimus. Samalla käydään läpi Teidän MRI-tutkimuksenne 
tulokset, peräsuolen painemittaustulokset ja mahdolliset oireet.  
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Mikäli ilmenee, että Teillä on kirurgista hoitoa vaativa sulkijalihasrepeämä, Teille suunnitellaan asianmukaista 
jatkohoitoa. 
Kutsu vastaanotolle lähetetään postitse, ja tarvittaessa tutkimuksen henkilökunta voi olla Teihin yhteydessä myös 
puhelimitse. 
Peräaukon sulkijalihasten painemittaus (Anaalimanometriatutkimus)  
Tutkimuksessa selvitetään peräsuolen ja sen sulkijalihaksen toimintaa sekä häiriöitä, kuten pidätyskyvyn 
puutetta. Tutkimus suoritetaan tutkittavan maatessa vasemmalla kyljellään. Mittausväline on ohut mittauskatetri, 
joka tutkimuksessa viedään peräsuoleen muutaman senttimetrin syvyyteen. Tutkimuksessa tehdään kaksi 
painemittausta kahdella eri katetrilla. Tutkimus on kivuton ja kestää noin puoli tuntia.  
MRI-tutkimus 
Magneettitutkimuksella saadaan tarkkoja kuvia elimistöstä radioaaltojen ja magneettikentän avulla. 
Tutkimuksessa ei käytetä röntgensäteilyä. Tutkimuksen ajan makaatte putkimaisessa laitteessa noin 20 
minuuttia, jolloin Teistä otetaan muutamien minuuttien pituisia kuvasarjoja.  
Saatu kuvamateriaali tallennetaan ja analysoidaan jälkikäteen. 
Peräsuolen sulkijalihasten ultraäänitutkimus (endoanaaliultraäänitutkimus) 
Peräsuolen sulkijalihasten ultraäänitutkimuksella saadaan kolmiulotteinen kuva Teidän sulkijalihaksestanne. 
Kuvat otetaan käyttämällä ultraäänianturia, joka laitetaan Teidän peräsuoleenne. Tutkimus kestää noin 2 
minuuttia ja on kivuton. 
Kuvat tallennetaan ja analysoidaan jälkikäteen. 
Tutkimuksen mahdolliset hyödyt 
Saatte tietoa sulkijalihasten tilanteesta, esimerkiksi siitä onko repeämä parantunut. Lisäksi selvitetään 
sulkijalihasten toimintaa ja sitä, miten repeämä on vaikuttanut elämänlaatuunne. Mikäli Teillä ilmenee hoitoa 
vaativa jälkirepeämä tai Teillä ilmenee vaikea-asteista ulosteen pidätyskyvyttömyyttä, tarjotaan Teille siihen 
hoitoa.  
Voi olla, että synnytyksen yhteydessä saatu repeämä on parantunut hyvin ja Teillä ei ole sulkijalihasten 
toiminnallisia häiriöitä. Tutkimuksesta saatu tieto auttaa parantamaan sulkijalihasrepeämien hoitoa ja 
diagnostiikkaa tulevaisuudessa. Tutkimuksen yhteydessä saatte tietoa terveydentilastanne. 
MRI-tutkimus, sulkijalihasten ultraäänitutkimus ja peräaukon painemittaus on todettu vaarattomiksi potilaalle. 
Tietojen luottamuksellisuus ja tietosuoja 
Tutkimuksessa henkilöllisyytenne sekä muut tunnistettavat tiedot ovat ainoastaan tutkimuksen henkilökunnan 
tiedossa, ja he kaikki ovat salassapitovelvollisia. Kaikkia Teistä kerättäviä tietoja käsitellään koodattuna siten, 
ettei yksittäisiä tietojanne pystytä tunnistamaan tutkimukseen liittyvistä tutkimustuloksista, selvityksistä tai 
julkaisuista.  
Tutkimusrekisteriin tallennetaan vain tutkimuksen tarkoituksen kannalta välttämättömiä henkilötietoja. Teidän 
yksilöintitietonne (syntymäaika, yhteystiedot jne.) käsitellään ja myös tallennetaan tutkimustiedoista erillään. 
Tutkimustuloksissa ja muissa asiakirjoissa Teihin viitataan tarvittaessa vain tunnistekoodilla. Rekisteriä 
säilytetään Vaasan keskussairaalassa viisi vuotta tutkimuksen päätyttyä. Tutkimusrekisteristä on laadittu 
henkilötietolain 10 §:n mukainen rekisteriseloste, jonka saatte halutessanne nähtäväksi. 
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Terveydentilaanne koskevia ja tutkimuksen kannalta tarpeellisia tietoja voidaan luvallanne kerätä myös muista 
terveydenhuollon toimintayksiköistä. Tutkijalääkäri voi tällöin hankkia tarvitsemansa tiedot henkilötunnuksenne 
avulla. Teillä on oikeus tarkastaa omat henkilötietonne ja tarvittaessa pyytää niihin korjauksia.  
Jos päätätte peruuttaa suostumuksenne tai osallistumisenne tutkimukseen keskeytyy jostain muusta syystä, 
keskeyttämiseen asti kerättyjä tietoja käytetään osana tutkimusaineistoa. 
Tutkimuksen kustannukset ja taloudelliset selvitykset 
Tutkimukseen liittyvät toimenpiteet kuuluvat kuntalaskutuksen piiriin. Tutkimukseen liittyvästä lääkärikäynnistä 
Teiltä peritään normaali poliklinikan käyntimaksu.      
Tutkittavien vakuutusturva  
Jos tutkimuksen takia tehdystä toimenpiteestä aiheutuu Teille henkilövahinko, voitte hakea korvausta.  
Tutkimuksesta aiheutuneista vahingoista haetaan korvausta potilasvakuutuksesta. Se korvaa potilasvahinkolain 
mukaisesti terveyden- ja sairaanhoidon yhteydessä aiheutuneita henkilövahinkoja laissa tarkemmin säädellyin 
edellytyksin. Potilasvakuutuskeskus huolehtii potilasvahinkojen korvauskäsittelystä. 
Jos Teillä on kysyttävää tutkimuksesta, voitte olla yhteydessä tutkijalääkäreihin.  
Heidän kanssaan voitte keskustella kaikista tutkimuksen aikana mahdollisesti ilmenneistä 
haittavaikutuksista tai muista mieltänne askarruttavista asioista.  
Yhteystiedot (tutkijalääkärit): 
Jaan Kirss jr   
Vaasan Keskussairaala  
Hietalahdenkatu 2-4 
65130 Vaasa 
puh: 06 213 1111 
Tarja Pinta  
Seinäjoen keskussairaala 
Hanneksenrinne 7 
60220 Seinäjoki 
puh: 06 415 4111 
 
Tutkimuksen vastuuhenkilö: 
prof. Mikael Victorzon 
Kirurgian professori, ylilääkäri 
Vaasan Keskussairaala/Turun Yliopisto  
Hietalahdenkatu 2-4 
65130 Vaasa 
puh: 06 213 1111 
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Information till deltagare i undersökningen (förlossning med skador på ändtarmsöppningens slutmuskel) 
Är en MRI-undersökning (Magnetisk resonanstomografi) av bäckenbotten lämplig för att konstatera eventuella 
skador på ändtarmsöppningens slutmuskel till följd av en förlossning? 
Du bjuds in att delta i ett undersökningsprojekt där man undersöker förekomsten av analinkontinens i samband 
med skador på ändtarmens slutmuskel. Du skulle vara en lämplig person för undersökningen, eftersom du vid 
förlossningen konstaterades ha fått en bristning som bland annat skadade ändtarmsöppningens slutmuskel. 
Informationen som följer beskriver undersökningsprojektet och ditt deltagande i det.  
Det är helt frivilligt att delta i den här undersökningen. Du kan vägra delta i undersökningen eller avbryta ditt 
deltagande i vilket skede som helst utan att uppge någon orsak.  
Den vård du erhåller är inte beroende av att du deltar i undersökningen.  
Forskningsläkaren kan bli tvungen att avbryta ditt deltagande. Om så skulle ske, kommer vi att samtala med dig 
om fortsatta åtgärder efter avslutandet. 
Läs igenom detta informationsbrev i lugn och ro. Om du har frågor kan du kontakta forskningsläkarna eller 
någon annan i undersökningspersonalen. Om du beslutar dig för att delta i undersökningsprojektet ber vi dig 
underteckna den bifogade blanketten för samtycke. 
Bakgrund 
En vaginal förlossning kan ofta leda till bristningar i slidan eller till och med i ändtarmsöppningen. 
Svårhetsgraden på bristningen fastställs av gynekologen genast efter förlossningen och i allmänhet åtgärdas 
bristningen omedelbart av gynekologen eller en kirurg specialiserad på matsmältningsorgan och buk. Cirka 3-6 
månader efter förlossningen kallas du på kontrollbesök till kirurgiska polikliniken för mag- och 
matsmältningsorgan, där man kontrollerar om resultatet av åtgärdandet av bristningen blev bra. 
Även om bristningen skulle ha blivit åtgärdad på bästa möjliga sätt, kan den som fått en bristning lida av 
problem med läckage av avföring. Symptomen kan vara lindriga så som läckage av gaser eller svårare som 
läckage av fast avföring.  
Syftet med undersökningen 
Syftet med den här undersökningen är att klargöra i vilken grad symptomen på bristning i ändtarmsöppningens 
slutmuskel motsvarar det man kan få fram via magnet-, ultraljudsbilder och tryckmätning av ändtarmsöppningen. 
Dessutom ombeds undersökningsdeltagarna uppskatta hur bristningen i slutmuskeln har påverkat livskvaliteten 
och förmågan att stå emot tarmläckage.   
Det här undersökningsprojektet genomförs av centralsjukhusen i Vasa och Seinäjoki i samarbete med Åbo 
universitets centralsjukhus. Registeransvarig för undersökningen är Vasa centralsjukhus som ansvarar för att 
hanteringen av personuppgifter i samband med undersökningen sker i enlighet med lagen. 
Om undersökningen  
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Du kommer att få frågeformulären, information om undersökningen och blanketten för samtycke postad hem till 
dig.  Om du vill delta i undersökningen ber vi dig skicka de ifyllda frågeformulären och den undertecknade 
blanketten för samtycke tillbaka till forskningsläkarna.   
Efter att du har undertecknat blanketten för samtycke, kommer du att få en tid till MRI-undersökning av 
bäckenbotten, tryckmätning av ändtarmsöppningen och tid till mottagning på kirurgiska polikliniken för mag- 
och matsmältningsorgan. Om du inte vill delta i undersökningen kommer du endast att få en tid till kirurgiska 
polikliniken. 
På kirurgiska polikliniken får du träffa någondera av forskningsläkarna Tarja Pinta eller Jaan Kirss. På 
poliklinikmottagningen utförs även en ultraljudsundersökning av ändtarmens slutmuskler. På samma gång går 
man igenom resultaten av MRI-undersökningen, tryckmätningen av ändtarmen och eventuella symptom.  
Om det visar sig att du har sådana bristningar i slutmuskeln som kräver kirurgisk vård, planerar vi en fortsatt 
vård som är mest lämplig för dig. 
Kallelsen till mottagningen skickas per post, men vid behov kan undersökningspersonalen även kontakta dig per 
telefon. 
Tryckmätning av ändtarmsöppningens slutmuskel (Anorektal manometri)  
Vid undersökningen klargör man hur ändtarmen och dess slutmuskler fungerar och om det finns eventuella 
störningar som oförmåga att hålla emot läckage. Under undersökningen ligger personen på sin vänstra sida. 
Trycket mäts med en tunn mätkateter som vid undersökningen förs in några centimeter i ändtarmen. Det görs två 
tryckmätningar med två olika katetrar vid undersökningen. Undersökningen är smärtfri och tar cirka en halv 
timme.  
MRI-undersökningen 
Med en magnetundersökning fås detaljrika bilder av organ och vävnader med hjälp av radiovågor och 
magnetfält. Ingen röntgenstrålning används vid undersökningen. När du undersöks ligger du inne i en 
tubliknande apparat i cirka 20 minuter medan några minuter långa bildserier tas.  
Bildmaterialet som fås sparas och analyseras i efterhand. 
Ultraljudsundersökning av ändtarmens slutmuskel (endoanal ultraljudsundersökning) 
Genom en ultraljudsundersökning av ändtarmens slutmuskel fås en tredimensionell bild av din slutmuskel. 
Bilderna tas med hjälp av en ultraljudssond som förs in i ändtarmen. Undersökningen tar cirka 2 minuter och är 
smärtfri. 
Bildmaterialet sparas och analyseras i efterhand. 
Eventuell nytta av undersökningen 
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Du får information om vilket tillstånd slutmuskeln befinner sig i, exempelvis om bristningen har läkt. Dessutom 
utreds hur väl slutmuskeln fungerar och hur bristningen har påverkat din livskvalitet. Ifall det konstateras att du 
har en efterbristning som kräver vård eller det konstateras en svår analinkontinens, så kommer du att erbjudas 
vård.  
Det kan hända att den bristning du fått i samband med förlossningen har läkts bra och att du inte har några 
funktionsstörningar i slutmuskeln. Informationen som fås från undersökningen förbättrar den framtida 
diagnostiseringen och vården av bristningar i slutmuskeln. I samband med undersökningen får du även 
information om ditt hälsotillstånd. 
MRI-undersökningar, ultraljudsundersökning av slutmuskeln och tryckmätning av ändtarmsöppning har 
konstaterats vara ofarliga för patienten. 
Uppgifternas konfidentialitet och integritetsskydd 
I detta undersökningsprojekt finns din identitet och andra identifierbara uppgifter tillgängliga endast för 
undersökningspersonalen som alla har tystnadsplikt. All data som samlas in om dig och prover som tas hanteras 
kodade, vilket gör att dina enskilda uppgifter inte kan identifieras varken i undersökningsresultat, utredningar 
eller publikationer.  
I undersökningsregistret sparas endast sådana personuppgifter som är nödvändiga för undersökningens syfte. 
Dina identifikationsuppgifter (födelsetid, kontaktuppgifter osv.) hanteras och sparas separat från 
undersökningsuppgifterna. I undersökningsresultaten och övriga dokument hänvisar man vid behov till dig 
enbart genom en identifieringskod. Registret uppbevaras på Vasa centralsjukhus i fem år efter att 
undersökningen avslutats. För undersökningsregistret finns en registerbeskrivning i enlighet med 10§ lagen om 
personuppgifter. Registerbeskrivningen kan du ta del av om du så önskar. 
Uppgifter om ditt hälsotillstånd och uppgifter nödvändiga för undersökningen kan med din tillåtelse inhämtas 
även från andra verksamhetsenheter inom hälsovården. Forskningsläkaren kan då skaffa de uppgifter han/hon 
behöver med hjälp av ditt personnummer. Du har rätt att kontrollera dina egna personuppgifter och vid behov be 
om korrigeringar.  
Om du beslutar dig för att dra tillbaka ditt samtycke eller ditt deltagande i undersökningen avbryts av någon 
annan orsak, kommer de ditintills insamlade uppgifterna att användas som en del av undersökningsmaterialet. 
Kostnader och ekonomiska utredningar för undersökningen 
Åtgärder som vidtas i anslutning till undersökningen täcks av den så kallade kommunfaktureringen. För 
läkarbesöket i anslutning till undersökningen debiteras du normal avgift för poliklinikbesök.      
Försäkringsskydd för dig som deltar i undersökningen  
Om någon åtgärd under undersökningen ger upphov till personskada hos dig, kan du ansöka om ersättning.  
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För skador som uppkommit under undersökningen söks ersättning från patientförsäkringen. Den ersätter i 
enlighet med patientskadelagen sådana personskador som uppkommit i samband med hälso- och sjukvård enligt 
vad som närmare stadgas i lagen. Patientförsäkringscentralen sköter behandlingen av patientskadeersättningar. 
Om du har frågor om undersökningen kan du kontakta forskningsläkarna.  
Med dem kan du diskutera alla biverkningar som eventuellt uppkommit under undersökningen, 
misstänkta symptom eller andra saker som du funderar över.  
 
 
Kontaktuppgifter (forskningsläkarna): 
Jaan Kirss jr   
Vasa centralsjukhus  
Sandviksgatan 2 -4 
65130 Vasa 
tel. 06 213 1111 
Tarja Pinta  
Seinäjoki centralsjukhus 
Hanneksenrinne 7 
60220 Seinäjoki 
tel. 06 415 4111 
Ansvarsperson för undersökningen: 
Mikael Victorzon 
Professor i kirurgi, överläkare 
Vasa centralsjukhus/Åbo universitet  
Sandviksgatan 2 -4 
65130 Vasa 
tel. 06 213 1111 
Jaan Kirss Jr.
DIAGNOSIS AND TREATMENT 
OF OBSTETRIC ANAL 
SPHINCTER INJURIES
TURUN YLIOPISTON JULKAISUJA – ANNALES UNIVERSITATIS TURKUENSIS
SARJA - SER. D OSA  - TOM. 1425 | MEDICA - ODONTOLOGICA | TURKU 2019
A
N
N
A
LES U
N
IV
ERSITATIS TU
RK
U
EN
SIS
Jaan Kirss Jr.
D
 1425
ISBN 978-951-29-7634-8 (PRINT)
ISBN 978-951-29-7635-5 (PDF)
ISSN 0355-9483 (Print) ISSN 2343-3213 (Online)
Pa
in
os
al
am
a 
O
y, 
Tu
rk
u 
, F
in
la
nd
  2
01
9
